Download as pdf or txt
Download as pdf or txt
You are on page 1of 32

INDIA DAILY

February 16, 2011

India

15-Feb 1-day1-mo 3-mo

Sensex

18,274

Nifty

Contents

Tata Steel: Solid operational performance

0.5

(3.1) (10.5)

Global/Regional indices
Dow Jones

Results

5,481

0.4 (3.1) (10.0)

12,227

(0.3)

3.7

9.1

2,804

(0.5)

1.8

11.6

Nasdaq Composite
FTSE

6,037

(0.4)

0.6

3.7

Nikkie

10,782

0.3

2.7

10.1

IVRCL Infrastructures: Revenue and EBITDA gains nullified by interest cost and
depreciation

Hang Seng

22,900

Jubilant Lifesciences: Disappointing quarter

Value traded India

Reliance Power: Expensive despite recent correction

KOSPI

2,009

(1.0) (5.7) (3.3)


(0.1) (4.7)

5.8

Cash (NSE+BSE)

171

Derivatives (NSE)

1,507

2,105 1,429

163

82

Deri. open interest

1,547

1,524 1,716

News Round-up
` India's textile, pharmaceuticals & services sectors could expect greater market
openings & automobile parts companies may face stiffer competition after the
country signs a trade agreement with Japan. (ECNT)
` Oil PSUs to hike jet fuel price 4.1% in metros. Oil marketing companies will hike
prices by an average of INR 2,204.48 a kilo litre. (THBL)

Forex/money market
Change, basis points
15-Feb 1-day
Rs/US$
10yr govt bond, %

1-mo

3-mo

45.5

29

8.1

(2)

(12)

Net investment (US$mn)

` Oil minister S Jaipal Reddy indicated that the govt. may not be able to clear Cairn
Energy Plc's move to sell control in its Indian arm to Vedanta Resources without
meeting state run ONGC's (ONGC IN) demand for an equitable royalty regime in the
Barmer oilfields that account for 90% of Cairn India's (CAIR IN) valuations. (TTOI)

14-Feb

MTD CYTD

FIIs

50

(369) (1,756)

MFs

56

100

(282)

Top movers -3mo basis

` Kishore Biyani is spinning off his consumer durables business, Ezone, into a separate
entity in order to maximize value from it. The promoter of Pantaloon Retail (PF IN) is
likely to induct strategic investors in 3 months. (ECNT)
` Reliance Industries Ltd (RIL IN) is now going after the tablet PC market, presently
dominated by Apple and Samsung at the premium end. (BSTD)
` GMR Infrastructures (GMRI IN) has raised around USD 113 mn of debt from India
Infrastructure Finance Company Ltd for modernizing Delhi International Airport.
(BSTD)
` Tata Motors (TTMT IN) said it was redrawing distribution plans of its joint venture
with Fiat as sales number of the Italian car maker had not been up to expectations.
Tata Motors global sales up 16% in January. (BSTD)
` TCS (TCS IN) expects to make its fully-integrated information technology solution for
small and medium enterprises, iON, a 1 bn on business in five years. TCS has already
signed up over 130 clients for iON and plans to take the customer base to 1,000 in a
year. (BSTD)
` Jindal Steel and Power Ltd (JSP IN) gets conditional green nod for Orissa plant. (THBL)
` Venus Remedies Ltd (VNR IN) announced the launch of its super speciality oncology
segment 'Passion Oncobiz', entailing an investment of USD 2 mn. (THBL)
` HCL Technologies (HCLT IN) sets up Global Enterprise Mobility lab in Singapore.
(THBL)
Source: ECNT= Economic Times, BSTD = Business Standard, FNLE = Financial Express, THBL = Business Line.

For Private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES.
REFER TO THE END OF THIS MATERIAL.

Change, %
Best performers

15-Feb 1-day

1-mo

3-mo

HCLT IN Equity

483.0

0.2

2.6

23.1

BHARTI IN Equity

329.2

0.5

(4.2)

5.0

NACL IN Equity

405.2

1.9

6.2

4.7

TCS IN Equity

1097.7

(1.3)

(2.0)

4.7

INFO IN Equity

3106.6

2.2

(3.1)

4.6

UT IN Equity

35.0

(3.6)

(39.2)

(53.0)

IVRC IN Equity

72.9

1.3

(33.7)

(45.1)

Worst performers

PUNJ IN Equity

72.5

(1.0)

(27.6)

(39.2)

IBREL IN Equity

115.3

(1.7)

(5.2)

(38.3)

RCOM IN Equity

101.6

4.4

(26.7)

(37.1)

BUY

Tata Steel (TATA)


Metals & Mining

FEBRUARY 16, 2011


RESULT
Coverage view: Attractive

Solid operational performance. Tata Steels standalone and consolidated EBITDA was
1.7% and 7% ahead of our estimate. However, below EBITDA line items such as high
tax provision and loss on impairment of assets led to net income miss. Corus
performance, on expected lines, was extremely weak. Tata Steel can deliver significant
earnings growth and stock performance over the next two years from cost-push based
steel price increase, growth from India brownfield expansion and overseas raw material
projects. We reinstate coverage with a BUY rating and end-FY2012E TP of Rs710.
Company data and valuation summary
Tata Steel
Stock data
52-week range (Rs) (high,low)
739-449
Market Cap. (Rs bn)
589.6
Shareholding pattern (%)
Promoters
32.5
FIIs
17.0
MFs
3.7
Price performance (%)
1M
3M
12M
Absolute
(0.9)
(0.3)
14.2
Rel. to BSE-30
2.2
10.8
0.2

Forecasts/Valuations
EPS (Rs)
EPS growth (%)
P/E (X)
Sales (Rs bn)
Net profits (Rs bn)
EBITDA (Rs bn)
EV/EBITDA (X)
ROE (%)
Div. Yield (%)

Price (Rs): 617


Target price (Rs): 710
BSE-30: 18,274

2010
2011E 2012E
(3.3)
64.4
69.7
(103.6) (2,051.8)
8.2
(186.8)
9.6
8.8
1,023.9 1,128.4 1,204.5
(3.3)
65.3
70.6
80.4
153.8 175.4
13.2
6.7
5.8
(1.5)
22.4
18.4
1.1
1.2
0.0

Indian operations shine with unexpected spike in steel realization


Tata Steel reported 3QFY11 standalone EBITDA of Rs28.2 bn (+30.8% yoy, +7.3% qoq), 1.7%
ahead of our estimate. Unexpected 8.8% qoq increase in realization to US$993/ ton (our estimate
was US$958/ ton) drove most of the surprise at the EBITDA level. Such a spike in realizations was
against the industry trend; Tata Steel management attributed this to qoq increase in long product
prices (Rs29,150/ ton, +6% qoq); in addition other steel products may have also contributed. Flat
product realizations declined sequentially. EBITDA/ ton increased to US$372, up 12.2% qoq. Net
income of Rs15.1 bn (+27% yoy, -26.7% qoq) missed our estimate on higher tax payout.
Consolidated net income missed our estimate, operational performance was strong
Tata Steel reported consolidated EBITDA of Rs34.2 bn (-6.7% qoq, +16.1% yoy). However, net
income of Rs8.3 bn (adjusted for extraordinary items) missed our and Street estimates. We
attribute the miss to two factors (1) Rs1.2 bn impairment charge in other income line after a fire in
Imjuiden plant destroyed a few facilities and (2) high effective tax rate of 39.7%.
Corus performance weak but on expected lines
On expected lines Corus reported a weak quarter with EBITDA of US$88 mn and EBITDA/ ton of
US$25 (-55% qoq, -33% yoy), though still better than our estimate. Lag impact of increase in raw
material prices (+9% qoq) on the P&L hurt profitability on a sequential basis. Performance was
helped by carbon credit sales of US$54 mn which in turn was partly offset by US$31 mn
impairment charge on certain Imjuiden assets. Tata indicates that carbon credit sales may recur as
long as plant capacity utilization is above 75%. Expect Corus profitability to improve in 4Q.
Maintain BUY on attractive valuations
Tata Steel trades at 5.9X FY2011E and 5.1X FY2012E EBITDA (adjusting for CWIP) and 8.8X
FY2012E earnings. Tata Steels brownfield expansion and investments in raw material projects can
deliver significant value in the medium term. Reinitiate with a BUY rating and end-FY2012E target
price of Rs710. We assign 6.5X to Tata Steel Indias FY2012E EBITDA and 5.5X to Corus.

For private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.

Tata Steel

Metals & Mining

Debt increases by 11% to US$13.2 bn


Tata Steels consolidated gross debt and net debt increased by ~US$1.1 bn qoq to US$13.2
bn and US$11.8 bn, respectively. The following factors may have led to the increase (1)
increase in working capital requirements in Europe due to increase in raw material prices, (2)
US$250 mn increase due to fluctuation in various foreign currency debt of Tata Steel India.
Tata Steel indicates that all its FX debt is fully hedged and (3) gross block which increased by
about a US$1 bn. Note that Tata Steel has aggressive capex plans of about US$2.3 bn for
FY2012E and US$2.1 bn for FY2013E.

Update on strategic projects


` DSO and New Millennium Corp. Tata Steel and New Millennium Corporation (NML) are in
exclusive talks with respect to development of two of the latters iron ore projects
LabMag and KeMag which cumulatively have reserves of up to 5.6 bn tons. This
exclusivity agreement will expire on Feb 28, 2011. As far as the Direct Shipping Ore
project is concerned, environmental approval for the first phase has been obtained and
commercial iron ore production will likely commence by 2QCY12E.
` Orissa project. Ground work to start construction for the Orissa project is already
underway. Tata Steel has secured the project site with boundary wall and fence and
started piling, besides foundation at the sinter plant has commenced. Construction of
other utilities is under progress. Initial phase of the Orissa plant will start with steelmaking capacity of 3 mtpa.

Few changes to our estimates


We build in our economists revised Re/US$ forecast of Rs45.6, Rs45.5 and Rs44 for
FY2011E, FY2012E and FY2013E, respectively, from Rs45.5, Rs44.5 and Rs44.1 earlier. We
have also fine tuned our HRC price assumption for India business over the next two years
and build in higher raw material prices. We also model recent issuance of 57 mn share at
Rs610 from its follow-on public offering. All factors results in 6.5% and 3.9% reduction in
our FY2012E and FY2013E EPS. Our EBITDA estimates remain largely unchanged. Exhibit 1
details the key changes to our estimate. BUY with FY2012E fair value of Rs710/ share.
We value standalone India operations of Tata Steel at 6.5X FY2012E EBITDA. This is higher
than historical levels, but we believe it is fair as it partly captures volume growth potential
for the India business. Put slightly differently, FY2012E EBITDA does not capture brownfield
expansion while the debt taken for this expansion is fully captured in the EV; assigning
higher multiple corrects this anomaly. We assign 5.5X to Corus and far-east operations, fair
noting lower profitability and lack of raw material security. We value listed investments at a
20% discount to the market price.
Our target price captures value from MOU signed by Corus for sale of Teeside Cast Products
(TCP) plant to SSI, Malaysia for US$500 mn; this adds Rs24 to fair value. However, our fair
value does not capture any upside from New Millennium Corp (Canadian iron ore project) or
Riversdale Mining investment. Note that Rio Tinto recently extended an open offer to
acquire Riversdale Mining at an equity value of US$3.9 bn. Tata Steels stake in Riversdale is
worth Rs40/share at Rios acquisition offer price.

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Metals & Mining

Tata Steel

Exhibit 1: Tata Steel, Change in estimates, March fiscal year-ends, 2011-13E (Rs mn)

2011E
Earnings (consolidated)
Net sales
EBITDA
Adj. PAT
EPS (Rs)
Volumes
India (mn tons)
International operations (mn tons)
Pricing
HRC price India (US$/ton)
Realization (US$/ton)

Revised estimates
2012E
2013E

2011E

Old estimates
2012E

2013E

2011E

% change
2012E
2013E

1,128,398
153,843
65,270
64.4

1,204,467
175,421
70,606
69.7

1,232,243
202,586
88,655
87.5

1,149,759
156,206
63,411
66.3

1,181,781
175,766
71,290
74.5

1,224,905
201,721
87,106
91.1

(1.9)
(1.5)
2.9
(2.9)

1.9
(0.2)
(1.0)
(6.5)

0.6
0.4
1.8
(3.9)

6.4
14.4

6.9
14.7

9.0
14.8

6.5
14.8

7.1
14.9

9.0
15.1

(1.7)
(2.4)

(2.8)
(1.6)

(2.3)

728
1,110

756
1,142

744
1,117

728
1,085

743
1,100

738
1,067

2.3

1.7
3.8

0.7
4.7

Source: Kotak Institutional Equities estimates

Following factors underpin our BUY rating on Tata Steel


` Cost-push based steel price increase will benefit Tata Steel India. We expect steel
prices to move up led by (1) a cost-push increaseiron ore prices have increased by 20%
in the past three months to US$187/ ton China CFR on modest revival in demand
combined with persistent supply issues and (2) seasonal increase in demand in 1HCY11E.
This should benefit integrated players such as Tata Steel, in our view. A US$10/ ton
increase in iron ore prices benefits earnings by 5%. We assume that Corus with a
converter business model will earn steady conversion margin and will have the ability to
pass on raw material price increase to consumers.
` Commissioning of value-accretive India capacity expansion. Tata Steel India is on
track to commission 2.9 mtpa steel-making capacity expansion in Jamshedpur by end2011. This will reflect in strong 27% volume growth in FY2013E. Note that the expanded
capacity will be self-sufficient on iron ore and generate profitability in excess of US$300/
ton. More important, EBITDA contribution from Indian operations may increase to 70%
of the overall EBITDA by FY2013E from less than 50% in FY2008-09. In our view, this will
significantly de-risk earnings.
` Benefits from overseas raw material projects may surprise on the upside.
Investments in raw material security, i.e. Riversdale Mining and New Millennium (iron ore
project in Canada) can potentially add US$300 mn to annual EBITDA. In any case, Tata
Steels holding is worth Rs40/share, based on Rios bid price for Riversdale. This value is
not captured in our target price and can be a positive catalyst.

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Tata Steel

Metals & Mining

Exhibit 2: Interim results of Tata Steel (standalone), March fiscal year-ends (Rs mn)

Net sales
Expenditure
Consumption of raw materials
Staff Cost
Power and fuel
Freight and handling
Other Expenditure
EBITDA
OPM (%)
Other income
Interest
Depreciation
Pretax profits
Extraordinaries
Tax
Net income
Ratios
EBITDA margin (%)
ETR (%)
EPS (Rs)
Segment revenue
Steel business
Others
Segment EBIT
Steel business
Others
Margins
Steel business
Others

3QFY11E
0.7
0.2
7.9
(12.7)
(4.8)
9.8
(3.3)
1.7

(% chg.)
3QFY10
16.0
8.5
15.4
(8.2)
13.9
10.8
7.0
30.8

2QFY11
4.1
2.2
12.5
(12.5)
(4.5)
10.2
(2.1)
7.3

(82.0)
(4.0)
(0.3)
0.4

26.6
(8.3)

(95.7)
(19.3)
9.2
26.8

26.5
27.0

(98.5)
(2.1)
1.7
(19.3)

3.6
(26.7)

64,971
4,488

16
8

4
(2)

20,141
163

21,764
43

14
5

6
297

34.5
21.7

33.5
32.9

(1.6)
32.9

1.4
(12.3)

3QFY11
73,974
(45,768)
(17,586)
(5,985)
(3,454)
(3,968)
(14,775)
28,205
38.1
113
(3,354)
(2,864)
22,100

(6,966)
15,135

3QFY11E
73,423
(45,683)
(16,301)
(6,859)
(3,626)
(3,614)
(15,282)
27,741
37.8
630
(3,493)
(2,871)
22,006

(5,502)
16,505

3QFY10
63,749
(42,180)
(15,241)
(6,523)
(3,032)
(3,581)
(13,803)
21,569
33.8
2,636
(4,157)
(2,622)
17,426

(5,508)
11,918

2QFY11
71,068
(44,777)
(15,637)
(6,837)
(3,615)
(3,603)
(15,086)
26,290
37.0
7,327
(3,425)
(2,815)
27,378

(6,726)
20,651

38.1
31.5
15.3

37.8
25.0
17.8

33.8
31.6
12.1

37.0
24.6
20.9

67,731
4,418

58,325
4,100

23,015
172

34.0
28.9

Source: Company, Kotak Institutional Equities estimates

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Metals & Mining

Tata Steel

Exhibit 3: Interim results of Tata Steel (consolidated), March fiscal year-ends (Rs mn)

Net sales
Expenditure
Consumption of raw materials
Staff Cost
Power and fuel
Freight and handling
Other Expenditure
EBITDA
OPM (%)
Other income
Interest
Depreciation
Pretax profits
Extraordinaries
Tax
Net income
Minority interest
Share of profit from associates
PAT after minority interest
Adjusted PAT
Income tax rate (%)
Ratios
EBITDA margin (%)
ETR (%)
EPS (Rs)
Segment revenue
Steel business
Others
Segment EBIT
Steel business
Others
Segment capital employed
Steel business
Others
Margins
Steel business
Others

3QFY11
290,895
(256,648)
(138,887)
(36,087)
(10,314)
(15,935)
(55,426)
34,246
11.8
(1,043)
(7,432)
(11,264)
14,506
1,223
(6,240)
9,489
161
380
10,030
8,266
39.7

3QFY11E
271,006
(238,986)
(120,191)
(35,862)
(9,609)
(14,009)
(59,314)
32,020
11.8
714
(6,969)
(10,889)
14,876

(4,909)
9,967
103
3
10,072
9,967
33.0

3QFY10
262,020
(232,514)
(104,828)
(41,999)
(10,845)
(14,451)
(60,393)
29,506
11.3
4,099
(7,630)
(11,547)
14,428
(1,957)
(8,148)
4,323
(148)
551
4,726
6,280
65.3

2QFY11
286,462
(249,739)
(124,064)
(38,275)
(9,967)
(14,676)
(62,757)
36,723
12.8
8,143
(6,637)
(10,781)
27,448
(316)
(7,450)
19,682
103
3
19,788
19,998
27.5

11.8
39.7
10.5

11.8
33.0
10.5

11.3
65.3
4.8

12.8
27.5
20.7

275,784
32,357

278,086
26,020

273,067
30,067

21,651
2,036

22,655
3,636

560,932
51,757

7.9
6.3

3QFY11E
7.3
7.4
15.6
0.6
7.3
13.7
(6.6)
7.0
(246.2)
6.6
3.4
(2.5)

27.1
(4.8)
56.9
NM
(0.4)
(17.1)

(% chg.)
3QFY10
2QFY11
11.0
1.5
10.4
2.8
32.5
11.9
(14.1)
(5.7)
(4.9)
3.5
10.3
8.6
(8.2)
(11.7)
16.1
(6.7)
(125.5)
(2.6)
(2.4)
0.5
(162.5)
(23.4)
119.5
(209.1)
(31.0)
112.2
31.6

(112.8)
12.0
4.5
(47.1)
(487.3)
(16.2)
(51.8)
56.9
NM
(49.3)
(58.7)

(0.8)
24.4

1.0
7.6

31,391
2,340

(4.4)
(44.0)

(31.0)
(13.0)

515,096
40,055

535,477
48,788

8.9
29.2

4.8
6.1

8.1
14.0

11.5
7.8

(3.6)
(55.0)

(31.7)
(19.2)

Source: Company, Kotak Institutional Equities estimates

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Tata Steel

Metals & Mining

Exhibit 4: Tata Steel, Quarterly analysis of cost-structure, March fiscal year-ends (US$/ton)
3Q 2009

4Q 2009

1Q 2010

2Q 2010

3Q 2010

4Q 2010

1Q 2011

2Q 2011

3Q 2011

Tata Steel India


Steel business
Average realization
Steel EBIT

855
246

672
147

752
228

737
239

783
270

864
342

940
387

842
282

918
312

Realization (US$/ ton)


Raw material cost
Employee cost
Power and fuel cost
Freight and handling
Other expenditure
EBITDA/ ton

906
204
109
50
50
222
270

723
299
74
32
41
122
155

803
232
73
47
46
162
243

798
202
74
42
44
173
264

847
205
88
41
48
185
280

927
160
87
43
48
201
387

1,014
151
91
56
55
217
444

912
203
89
47
47
196
332

993
238
81
47
54
200
372

Tata Steel (Consolidated)


Average realization
Steel EBIT
Steel EBITDA

1,130
81
117

878
(40)
(12)

917
(37)
(3)

901
(22)
16

961
78
104

1,003
118
136

1,068
119
155

1,010
116
126

1,083
85
133

Realization (US$/ ton)


Raw material cost
Employee cost
Power and fuel cost
Freight and handling
Other expenditure
EBITDA/ ton

1,116
616
150
49
47
158
97

891
514
130
38
44
164
1

901
460
153
37
45
207
(1)

846
395
145
34
49
211
12

906
362
145
37
50
209
102

942
361
135
34
51
199
163

985
375
137
35
57
220
161

1,059
459
142
37
54
232
136

1,142
545
142
40
63
218
134

Source: Company, Kotak Institutional Equities estimates

Exhibit 5: Tata Steel, valuation, March fiscal year-ends, 2012E basis (Rs mn)

Tata Steel standalone


Tata Steel Europe
Tata Steel thailand and other businesses
Total Enterprise Value

EBITDA

Multiple

(Rs mn)

(X)

Enterprise value

EV

(Rs mn)

(Rs/share)

122,600

6.5

799,353

789

44,473

5.5

244,601

241

6,515

5.5

35,834

35

1,079,788

1,066

Consolidated group net debt

400,056

Total borrowings

400,056

395

Arrived market capitalization

679,732

671

Add: Value of investments


Arrived market capitalization
Target price (Rs)

39,530

39

719,262

710
710

Source: Kotak Institutional Equities estimates

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Metals & Mining

Tata Steel

Exhibit 6: China import iron-ore fines from India (China CFR) prices (US$/ton)

China CFR 63% Fe

250
200
150
100
50

Feb-11

Oct-10

Jun-10

Feb-10

Oct-09

Jun-09

Feb-09

Oct-08

Jun-08

Feb-08

Oct-07

Jun-07

Feb-07

Oct-06

Jun-06

Feb-06

Oct-05

Feb-05

Jun-05

Source: Bloomberg, Kotak Institutional Equities estimates

Exhibit 7: Tata Steel, Key assumptions, March fiscal year-ends, FY2008-2013E (Rs mn)

2008

2009

2010

2011E

2012E

2013E

705
4.8
394

749
5.2
380

635
6.2
307

728
6.4
389

756
6.9
391

744
9.0
355

1,034
22.8
88

1,254
19.0
103

981
14.2
(20)

1,070
14.4
58

1,060
14.7
67

1,055
14.8
77

42.5

46.0

47.3

45.6

45.5

44.0

Tata Steel (India)


Benchmark HRC Price (US$/ton)
Volume (mn tons)
EBITDA/ton (US$/ton)
Corus
Average realization (US$/ ton)
Volume (mn tons)
EBITDA/ton (US$/ton)
Re/US$ rate

Source: Company, Kotak Institutional Equities estimates

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Tata Steel

Metals & Mining

Exhibit 8: Tata Steel (standalone), Profit model, balance sheet and cash flow model, March fiscal year-ends, 2008-2013E (Rs mn)
2008

2009

2010

2011E

2012E

2013E

Profit model (Rs mn)


Net sales
EBITDA
Other income
Interest
Depreciation
Profit before tax
Extraordinaries
Taxes
Profit after tax
Fully diluted EPS (Rs)

196,910
80,138
2,428
(7,865)
(8,346)
66,355
4,309
(23,793)
46,870
47.5

243,157
91,334
3,083
(11,527)
(9,734)
73,156

(21,139)
52,017
52.7

250,220
89,521
8,538
(15,084)
(10,832)
72,143

(21,675)
50,468
51.2

289,175
113,490
8,664
(13,428)
(11,475)
97,251
20,700
(28,308)
89,643
72.9

318,985
122,600
2,865
(12,930)
(13,490)
99,046

(29,714)
69,332
68.4

382,533
141,098
2,865
(10,448)
(17,616)
115,900

(34,770)
81,130
80.1

Balance sheet (Rs mn)


Equity
Deferred tax liability
Total Borrowings
Current liabilities
Total liabilities
Net fixed assets
Capital work in progress
Investments
Cash
Other current assets
Miscellaneous expenditure
Total assets

218,282
6,818
234,942
78,401
538,443
82,561
43,675
41,032
4,650
364,974
1,551
538,443

242,319
5,857
324,188
100,077
672,441
109,945
34,877
423,718
15,906
86,945
1,051
672,442

371,688
8,677
252,392
99,568
732,324
121,624
38,436
449,797
32,341
90,126

732,324

503,046
9,856
237,392
86,690
836,984
125,149
98,436
449,097
59,500
104,802

836,984

563,286
10,847
207,392
93,200
874,724
166,660
98,436
449,097
48,824
111,708

874,724

635,323
12,006
177,392
104,947
929,668
284,044
8,436
449,097
67,210
120,880

929,668

60,778
1,764
(23,951)
38,591

66,599
7,373
(27,711)
46,261

71,874
11,818
(20,237)
63,455

102,297
(8,849)
(75,000)
18,448

83,812
(396)
(55,000)
28,417

99,904
2,574
(45,000)
57,479

40.7
35.9
1.1
1.0
2.7
26.4
16.7

37.6
30.1
1.3
1.1
3.0
22.7
13.9

35.8
28.8
0.7
0.5
2.1
16.5
12.3

39.2
40.8
0.5
0.3
1.3
20.5
14.1

38.4
31.1
0.4
0.2
1.0
13.0
12.1

36.9
30.3
0.3
0.1
0.5
13.5
13.1

Free cash flow (Rs mn)


Operating cash flow excl.working capital
Working capital changes
Capital expenditure
Free cash flow
Ratios
EBITDA margin (%)
EBT margin (%)
Debt/equity (X)
Net debt/equity (X)
Net debt/EBITDA (X)
RoAE (%)
RoACE (%)

Source: Company, Kotak Institutional Equities estimates

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Metals & Mining

Tata Steel

Exhibit 9: Tata Steel (consolidated), Profit model, balance sheet and cash flow model, March fiscal year-ends, 2008-2013E (Rs mn)
2008

2009

2010

2011E

2012E

2013E

Profit model (Rs mn)


Net sales
EBITDA
Other income
Interest
Depreciation
Profit before tax
Extraordinaries
Taxes
Profit after tax
Minority interest
Share in profit/(loss) of associates
Reported net income
Adjusted net income
Fully diluted EPS (Rs)

1,315,336
177,824
4,759
(40,854)
(41,370)
100,359
63,351
(40,493)
123,218
(1,399)
1,682
123,500
110,441
112.0

1,473,293
181,277
2,657
(32,902)
(42,654)
108,378
(40,945)
(18,940)
48,492
409
607
49,509
61,750
62.6

1,023,931
80,427
11,859
(30,221)
(44,917)
17,147
(16,837)
(21,518)
(21,208)
(152)
1,269
(20,092)
(3,255)
(3.3)

1,128,398
153,843
8,962
(28,076)
(45,048)
89,680
20,700
(30,906)
79,474
400
507
80,381
65,270
64.4

1,204,467
175,421
2,408
(31,398)
(47,166)
99,264

(29,779)
69,485
360
761
70,606
70,606
69.7

1,232,243
202,586
3,063
(30,147)
(50,401)
125,100

(37,530)
87,570
324
761
88,655
88,655
87.5

Balance sheet (Rs mn)


Equity
Deferred tax liability
Total Borrowings
Current liabilities
Minority interest
Total liabilities
Net fixed assets
Capital work in progress
Goodwill
Investments
Cash
Other current assets
Miscellaneous expenditure
Total assets

287,015
24,545
590,973
339,163
8,327
1,250,022
331,187
88,476
180,500
33,675
42,319
572,309
1,556
1,250,022

217,700
17,094
653,732
313,109
8,949
1,210,583
364,175
88,880
153,649
64,111
61,484
477,229
1,055
1,210,583

230,208
16,541
531,004
309,639
8,841
1,096,232
365,252
92,706
145,418
54,178
67,878
370,800

1,096,232

352,325
17,645
476,004
319,895
8,441
1,174,309
375,204
134,706
145,418
54,685
43,818
420,477

1,174,309

413,839
18,141
461,004
336,049
8,081
1,237,113
416,148
134,206
145,418
55,447
41,635
444,259

1,237,113

493,402
18,767
446,004
342,270
7,757
1,308,198
525,157
44,206
145,418
56,208
84,266
452,943

1,308,198

117,771
(22,227)
(79,967)
15,578

116,077
2,254
(83,608)
34,723

25,583
46,465
(69,472)
2,577

114,669
(39,421)
(97,000)
(21,752)

114,740
(7,628)
(87,610)
19,501

135,534
(2,463)
(69,410)
63,661

13.5
10.4
2.1
1.9
3.0
51.0
14.6

12.3
9.4
3.0
2.6
3.1
24.5
9.9

7.9
3.5
2.3
1.9
5.5
(1.5)
(34.8)

13.6
9.6
1.4
1.2
2.7
22.4
12.1

14.6
10.6
1.1
1.0
2.3
18.4
13.1

16.4
12.4
0.9
0.7
1.7
19.5
14.6

Free cash flow (Rs mn)


Operating cash flow excl. working capital
Working capital changes
Capital expenditure
Free cash flow
Ratios
EBITDA margin (%)
EBIT margin (%)
Debt/equity (X)
Net debt/equity (X)
Net debt/EBITDA (X)
RoAE (%)
RoACE (%)

Source: Company, Kotak Institutional Equities estimates

10

KOTAK INSTITUTIONAL EQUITIES RESEARCH

SELL

Reliance Power (RPWR)


Utilities

FEBRUARY 16, 2010


RESULT
Coverage view: Cautious

Expensive despite recent correction. Reliance Power (RPWR) stock has corrected by
~35% in the past three months and is now trading at 1.9X FY2012E book. We,
however, maintain our negative stance on account of (1) lack of fuel security for gasbased capacities, (2) dilution of earnings (and valuation) due to merger with RNRL, and
(3) inferior profitability of UMPPs. Operating results in 3QFY11 were ahead of our
estimate on account of better-than-estimated availability. Reiterate SELL.
Company data and valuation summary
Reliance Power
Stock data
193-106
52-week range (Rs) (high,low)
Market Cap. (Rs bn)
290.7
Shareholding pattern (%)
Promoters
84.8
FIIs
3.8
MFs
0.3
Price performance (%)
1M
3M
12M
Absolute
(17.5) (33.4) (14.0)
Rel. to BSE-30
(14.8) (25.9) (24.5)

Forecasts/Valuations
EPS (Rs)
EPS growth (%)
P/E (X)
Sales (Rs bn)
Net profits (Rs bn)
EBITDA (Rs bn)
EV/EBITDA (X)
ROE (%)
Div. Yield (%)

2011
2.9
0.1
42.5
11.5
8.0
3.0
220.5
5.2
0.0

2012E
4.0
38.4
30.7
41.9
11.1
15.9
48.0
6.6
0.0

Price (Rs): 121


Target price (Rs): 115
BSE-30: 18,274

2013E
2.5
(36.7)
48.4
121.5
7.0
43.7
18.8
4.0
0.0

Operating results beat estimates on better availability


RPWR reported revenues of Rs2.5 bn, operating profit of Rs617 mn and net income of Rs1.4 bn
against our estimates of Rs2.1 bn, Rs348 mn and Rs1.9 bn, respectively. Higher-than-estimated
revenues were primarily on account of better availability during the quarter (~80%) resulting in
better-than-estimated average realizations. Management has indicated that Rosa has secured the
permission to blend imported coal and availability and PLF should improve further going forward.
Net income miss was primarily driven by significantly lower-than-estimated other income (Rs1 bn
against our estimate of Rs2.9 bn) which was partially offset by (1) lower depreciation on account
of change in depreciation policy for Rosa plant to align with UPERC rates (resulting in depreciation
being lower by Rs297.9 mn) and (2) tax write-backs on account of higher provisioning in previous
quarters.
Maintain SELL despite recent correction as execution and fuel risks remain high
RPWR stock has corrected by ~35% in past three months and is now trading at 1.9X FY2012E
book. We, however, maintain our cautious stance on RPWR given the limited visibility on nearterm earnings growth and high degree of execution and fuel risks embedded in the portfolio.
Continued uncertainty over availability of gas on account of slow ramp-up of supply from KG-D6
block makes us skeptical about the prospects on securing gas in the near term for the proposed
9,200 MW of gas-based capacities (including near-term 2,400 MW at Samalkot). Further, we
believe that UMPPs will not be the value driver for RPWR as they have been bid at a relatively
lower tariff structure. Our DCF-based valuation for Sasan and Krishnapatnam implies a P/B of 1X
on the total equity investment for these projects.
Retain SELL with a revised target price of Rs115/share
We maintain our SELL rating on RPWR with a revised target price of Rs115/share (previously
Rs135/share) as we adjust for dilution upon merger with RNRL. Our target price implies a P/B of
1.8X on FY2012E book value. We have revised our EPS estimates for FY2011E to Rs2.9/share
(previously Rs3.9/share) and for FY2012E to Rs4/share (previously Rs5.3/share) as we account for
dilution upon merger with RNRL and delays in commissioning of projects.

For private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.

Utilities

Reliance Power

Exhibit 1: Operating results beat estimates on better availability


Interim results for RPWR, March fiscal year-ends (Rs mn)

Net sales
Operating costs
Cost of fuel
Personnel costs
Other expenses
EBITDA
EBITDA margin (%)
Other income
Interest & finance charges
Depreciation
PBT
Provision for tax (net)
Net profit
Extraordinary

3QFY11
2,513

3QFY11E
2,108

3QFY10

(121)
(146)
(267)

2QFY11
1,687

(1,242)
(196)
(458)
617
25
1,038
(685)
(77)
892
544
1,436

(1,242)
(193)
(324)
348
17
2,912
(520)
(400)
2,341
(445)
1,896

1,792

(2)
1,523
(186)
1,336

(997)
(153)
(254)
282
17
3,437
(499)
(375)
2,845
(497)
2,348

EBITDA margin (%)


Tax rate (%)

25
(61)

17
19

12

Key operating parameters


Units generated (MU)
PLF (%)
Average realization (Rs/kwh)
Cost of fuel (Rs/unit)
O&M (Rs/unit)

719
55
3.7
1.7
0.9

690
53
3.3
1.8
0.8

3QFY11E
19

(% Chg.)
3QFY10

2QFY11
49

FY2010
207

FY2011E
11,530

(221)
(245)
(815)
(1,073)
(518)
8,227
(70)
(57)
7,026
(187)
6,839

(5,027)
(1,200)
(2,286)
3,016
26
8,961
(2,219)
(798)
8,960
(949)
8,011

17
17

(518)
3

26
11

545
42
3.3
1.8
0.7

149
69
1.4
1.5
7.1

2,989
66
3.9
1.7
1.2

77

(331)

119

(62)

(41)

(69)

(24)

(39)

(% Chg.)
5,463
2,175
390
181
(381)

28
17

Source: Company, Kotak Institutional Equities estimates

Exhibit 2: Gross value of power projects (Rs bn)


Capacity
Project
Type
(MW)
Rosa I
Coal
600
Rosa II
Coal
600
Butibori
Coal
600
Sasan UMPP
Coal
3,960
Krishnapatnam UMPP
Imported coal
4,000
Dadri
Gas
6,400
Chitrangi
Coal
3,960
Total
20,120

Equity Investment
(Rs bn)
6.0
6.2
7.0
41.0
48.6
38.4
47.5

P/B
(X)
1.5
-0.2
5.2
1.0
1.0
1.9
3.5
1.9

RPWR's
share
100%
100%
74%
100%
100%
100%
100%

Value
(Rs bn)
9.2
-0.9
26.7
42.2
47.7
74.3
166.5
365.6

Cost of equity
(%)
12.5
12.5
12.5
12.5
12.5
15.0
15.0

Source: Company, Kotak Institutional Equities estimates

Exhibit 3: Our SOTP-based target price is Rs115/share


Valuation of RPWR

Gross value of power projects


Add: Equity to be invested
Add: Cash and cash and cash equivalent
Net Value

Valuation
(Rs bn)
(Rs/share)
366
130
(200)
(71)
157
56
322
115

Source: Company, Kotak Institutional Equities estimates

12

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Reliance Power

Utilities

Status of power projects and captive coal blocks


We highlight below the execution status of key power projects of RPWR as highlighted by
the management.
` Rosa II (600 MW) the project has achieved all necessary milestone and construction is in
progress. The project has linkage from CCL (E grade coal). The project is likely to
commission by end-FY2012E.
` Butibori (600 MW) the project has achieved all necessary milestone and construction is
in progress. The project has linkage from WCL (D grade coal). The project is likely to
commission by June 2012.
` Sasan UMPP (3,960 MW) all necessary clearances and approvals in place and
construction has commenced. Management has indicated that production from Sasan
coal block is likely to commence by 2012. Peak production is likely to be 25 mtpa. A part
of the coal will be used for Chitrangi project. Management has guided for commissioning
of first unit by January 2012.
` Krishnapatnam UMPP (3,960 MW) all necessary clearances and approvals in place.
RPWR has acquired 3 coal mines in Indonesia for the project. Management has indicated
that production from Indonesian mines will commence by mid-2013 and RPWR will likely
ship in 25 mtpa of Indonesian coal. Indonesian coal will be inferior quality coal (GCV of
4,000 kcal/kg) and boilers for Krishnapatnam UMPP will be designed accordingly.
Management has guided for commissioning of first unit by September 2013.
` Tilaiya UMPP (3,960 MW) the project is yet to achieve financial closure. Management
has indicated that production from Tilaiya coal block will likely commence by 2013. Peak
production from the project will be 40 mtpa, part of which will be used to fuel expansion
at Tilaiya.
` Chitrangi (3,960 MW) the project is yet to achieve financial closure and acquire the
entire land for the plant. Project will use excess coal from captive coal blocks allocated for
Sasan UMPP. Management has guided for commissioning of first unit by September 2013.
Exhibit 4: Progress on UMPPs have been sedate with both Sasan and Krishnapatnam missing original commissioning guidance
Execution status of near-term projects of RPWR

Project
Rosa II

Capacity
(MW)
600

Butibori

600

Land

Fuel

Enviroment
clearance

Financial
Closure

EPC
award

D
D

D
D
D
D
D
D

D
D
D
D
D
D

D
D
D
D
WIP

D
D
D
U
U

Sasan

3,960

WIP

Krishnapatnam

4,000

WIP

Chitrangi

3,960

WIP

Tilaya

4,000

WIP

Expected
CoD
Mar-12
Jun-12
Jun-13
Jul-15
Jul-14
Jun-17

Source: Company, Kotak Institutional Equities estimates

KOTAK INSTITUTIONAL EQUITIES RESEARCH

13

Utilities

Reliance Power

Exhibit 5: Profit model, balance sheet, cash model of RPWR, March fiscal year-ends, 2009-2013E (Rs
mn)
2009

2010

2011E

2012E

2013E

(1,031)
3,604

(2)
2,570
(119)

2,445

2,445
1.1

207
(1,073)
8,227
(70)
(57)
7,026
(187)

6,839

6,839
2.9

11,530
3,016
8,961
(2,219)
(798)
8,960
(310)
(639)
1
8,011

8,011
2.9

41,890
15,918
10,125
(5,934)
(4,770)
15,339
(1,542)
(2,286)
(421)
11,090

11,090
4.0

121,541
43,734
5,085
(22,033)
(14,823)
11,963
(2,665)
(1,171)
(1,103)
7,024

7,024
2.5

Balance sheet
Paid-up common stock
Total shareholders' equity
Deferred taxation liability
Minority interest
Total borrowings
Total liabilities and equity
Net fixed assets
Capital work-in progress
Investments
Cash
Net current assets (excl. cash)
Net current assets (incl. cash)
Total assets

23,968
137,791

13,325
151,116
2,879
46,780
103,172
216
(1,931)
(1,715)
151,116

23,968
144,630

22,406
167,037
23,408
68,029
79,152
1,338
(4,890)
(3,552)
167,037

28,051
167,294
689
1,679
415,223
584,885
100,160
432,280

42,386
10,059
52,445
584,885

28,051
178,384
2,975
2,100
493,229
676,688
238,153
398,568

22,491
17,475
39,966
676,688

28,051
185,408
4,146
3,203
535,197
727,954
569,471
126,960

5,341
26,181
31,523
727,954

Free cash flow


Operating cash flow, excl. working capital
Working capital changes
Capital expenditure
Free cash flow

2,447
(4,065)
(39,351)
(40,969)

6,896
2,959
(41,835)
(31,979)

9,447
(14,950)
(441,801)
(447,303)

18,567
(7,416)
(109,051)
(97,900)

24,121
(8,706)
(74,533)
(59,118)

10
1.8
57.5

15
4.8
60.3
4.3

221
5.1
59.9
2.7

261
6.4
64.7
2.5

281
3.9
67.6
3.3

Profit model
Net revenues
EBITDA
Other income
Interest (expense)/income
Depreciation
Pretax profits
Tax
Deferred taxation
Minority interest
Net income
Extraordinary items
Reported profit
Earnings per share (Rs)

Ratios
Net debt/equity (%)
Return on equity (%)
Book value per share (Rs)
ROCE (%)

Source: Company, Kotak Institutional Equities estimates

14

KOTAK INSTITUTIONAL EQUITIES RESEARCH

BUY

IVRCL (IVRC)
Construction

FEBRUARY 15, 2011


RESULT
Coverage view: Attractive

Revenue and EBITDA gains nullified by interest cost and depreciation. IVRCL
delivered reasonable revenues growth of 15% yoy in 3QFY11, however, higher interest
cost and depreciation led to flat PAT yoy. The management reduced FY2011 revenue
guidance to Rs62.5 bn (may still be aggressive as we build Rs58.2 bn). Debt and
working capital remain stable on a qoq basis, a partial tie up of equity for BOT assets
may help push execution as concession agreement, land, financial closure make
progress. Retain BUY as stock trades at 4X FY2012E P/E adj. for equity holdings.
Company data and valuation summary
IVRCL
Stock data
195-60
52-week range (Rs) (high,low)
Market Cap. (Rs bn)
19.2
Shareholding pattern (%)
Promoters
9.5
FIIs
57.7
MFs
7.9
Price performance (%)
1M
3M
12M
Absolute
(34.5) (48.4) (54.7)
Rel. to BSE-30
(32.1) (42.9) (59.8)

Forecasts/Valuations
EPS (Rs)
EPS growth (%)
P/E (X)
Sales (Rs bn)
Net profits (Rs bn)
EBITDA (Rs bn)
EV/EBITDA (X)
ROE (%)
Div. Yield (%)

2011
7.0
(11.7)
10.3
58.3
1.9
5.5
7.0
9.6
0.6

2012E
8.9
28.1
8.0
72.7
2.4
6.9
6.0
11.2
0.6

2013E
12.6
40.7
5.7
92.5
3.4
8.8
4.9
13.9
0.6

Reasonable revenue growth nullified by higher interest cost and depreciation


IVRCL reported revenues of Rs14.2 bn (up 15% yoy) and EBITDA margins of 9.9% (up 90 bps yoy)
led by lower raw material cost as a percentage of sales. The net profit line disappointed though,
led by higher interest cost of Rs592 mn (vs Rs372 mn last year and Rs480 mn in 2QFY11) and
depreciation cost of Rs199 mn (up 43% yoy) led to flat PAT of Rs423 mn. For 9MFY11, revenues
are Rs36 bn and EBITDA margin at 9.3% are flat yoy with higher interest cost and depreciation
increase leading to decline in PAT of 26%.

Price (Rs): 72
Target price (Rs): 125
BSE-30: 18,202

QUICK NUMBERS
Revenues at Rs14.2
bn up 15% yoy
EBITDA margins
expands 90 bps yoy
to 9.9%
Net PAT at Rs423
mn flat yoy due to
interest cost (up
59% yoy) and
depreciation (up
43% yoy)

Revises full year guidance of Rs62.5 bn; we build in full year revenues of Rs58.2 bn
The management reduced the FY11 revenues guidance to Rs62.5 bn. The present guidance still
implies a strong growth of 35% in the last quarter. We believe this would be difficult to achieve
and have built in FY2011E revenues of Rs58.2 bn, implying yoy revenue growth of 18% in 4QFY11.
Equity for BOTs partly tied upmay scale up execution; IVRCL parent not to invest directly
Present portfolio of IVRCL Assets BOT projects requires incremental equity of about Rs13.5 bn.
Funds up to Rs6.5 bn are already tied up through (1) issue of compulsorily convertible debentures
of Rs2.5 bn to IFCI (2) Rs1.5 bn investment from UTI and (3) Rs2.5 bn NCDs. The rest are to be
funded from the stake sale of existing and upcoming BOT projects, land sales as well as equity
dilution in IVR Prime. IVRCL Infra. as a parent entity is not likely to invest in IVR Prime to fund the
equity of BOT projects.
Revise est. on back of higher interest cost; retain BUY on valuation, visibility and likely pick up
We have revised our FY2011E, FY2012E and FY2013E estimate to Rs7 (Rs7.7 earlier), Rs8.9
(Rs10.3 earlier) and Rs12.6 (Rs15.7) primarily based on higher interest cost versus earlier estimates.
We have revised our target price to Rs125 from Rs190 earlier based on (1) using 10X multiple now
versus 13X earlier, (2) lower valuation of listed subsidiaries (Rs20 impact) and (c) reduction in
earnings estimates. We retain our BUY rating as (1) execution of road projects may pick up as a
part of equity gets tied up, and agreements and financial closures are completed, (2) attractive
valuation 4X FY2012E P/E adjusted for equity holdings in IVR Prime and HDO, (3) order book
visibility.

For private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.

Construction

IVRCL

Result disappoint on interest cost and depreciation


IVRCL reported revenues of Rs14.2 bn, up 15% yoy. The company reported EBITDA margin
of 9.9%, up 90 bps yoy (9.0% in 3QFY10) and marginally better than our estimates of 9.5%.
The margin expansion was led by lower raw material cost as a percentage of sales. The
revenue and margin gains resulted in 26% yoy EBITDA growth to Rs1404 mn. IVRCL
disappointed on interest cost and depreciation leading to a net PAT of Rs433 mn, down 1%
yoy and 3.3% below our estimate of Rs437 mn. Interest cost increased 59% yoy to Rs592
mn due to the interest rate increase. Depreciation also increased significantly by 43% to
Rs199 mn.
For the nine months ending December 31, 2010, IVRCL reported flat revenues of Rs36 bn
and EBITDA of Rs3.36 bn. As in 3QFY11, the company disappointed on below EBITDA line
items leading to 9MFY11 net PAT contraction of 26% to Rs937 mn.
Revenue and EBITDA margins gains nullified by higher interest cost and depreciation
IVRCL - 3QFY11 - key numbers (Rs mn)

Net Sales
CoGS
Constrn, stores & spares
Subcontracting exp.
Masonry & labour
Staff cost
Other expenditure
Expenditure
EBITDA
Other income
PBIDT
Interest
Depreciation
Profit before tax
Tax
Profit after tax

3QFY11 3QFY11E
14,188
13,199
(11,769)
(5,325)
(1,894)
(4,551)
(604)
(411)
(12,784) (11,945)
1,404
1,254
11
54
1,415
1,308
(592)
(486)
(199)
(170)
625
653
(202)
(215)
423
437

3QFY10
12,347
(10,498)
(4,263)
(2,563)
(3,672)
(479)
(256)
(11,233)
1,115
39
1,153
(372)
(139)
643
(216)
427

2QFY11
10,750
(8,812)
(4,095)
(1,684)
(3,033)
(633)
(352)
(9,797)
953
57
1,010
(480)
(184)
345
(112)
233

Order book
Order backlog
Order booking

242,000
16,188

173,428
41,275

240,000
53,450

85.0
3.9
2.1
9.0
5.2
3.5
33.6

82.0
5.9
3.3
8.9
3.2
2.2
32.6

Key ratios (%)


CoGS/Sales
Staff cost/sales
Other expenditure/sales
EBITDA margin
PBT Margin
Net Profit margin
Effective tax rate

83.0
4.3
2.9
9.9
4.4
3.0
32.3

9.5
4.9
3.3
33.0

% change
yoy
14.9
12.1
24.9
(26.1)
23.9
26.1
60.6
7.0
13.8
12.0
26.0
(79.3)
(71.2)
8.2
22.7
21.8
59.0
17.2
43.3
(4.3)
(2.8)
(6.4)
(6.6)
(3.3)
(0.9)

vs est.
7.5

39.5
(60.8)

qoq
32.0
33.6
30.0
12.4
50.0
(4.6)
16.9
30.5
47.3
(80.2)
40.1
23.2
7.9
80.9
79.4
81.7

0.8
(69.7)

9MFY11
36,002
(29,703)
(13,026)
(5,479)
(11,198)
(1,888)
(1,045)
(32,637)
3,365
76
3,442
(1,525)
(540)
1,376
(440)
937

82.5
5.2
2.9
9.3
3.8
2.6
31.9

9MFY10
35,386
(30,158)
(13,311)
(7,271)
(9,576)
(1,299)
(673)
(32,130)
3,255
135
3,390
(1,115)
(401)
1,874
(608)
1,265

% change
1.7
(1.5)
(2.1)
(24.6)
16.9
45.3
55.4
1.6
3.4
(43.5)
1.5
36.8
34.7
(26.6)
(27.8)
(26.0)

#DIV/0!
#DIV/0!

85.2
3.7
1.9
9.2
5.3
3.6
32.5

Source: Company, Kotak Institutional Equities

Road projects execution slow as some projects may be just getting ready for
execution now
The slowdown in execution of the roads segment projects is reflected in the revenue
contribution of this segment (transportation segment) of 12% of the total 9MFY11 revenues
versus a backlog contribution of about 27%. We believe water resources and irrigation
segments have contributed their fair share to the revenues (equal revenue and backlog
contribution) while the buildings segment has recorded a strong revenue contribution of
about 24% versus a backlog contribution of 19%.

16

KOTAK INSTITUTIONAL EQUITIES RESEARCH

IVRCL

Construction

Segment wise break-up of IVRCL's order book and revenues for 1HFY11
9MFY11 revenues (Rs36 bn)

9MFY11-end backlog (Rs242 bn)


Oil & Gas
1%
Electrical
7%

Oil & Gas


14%
Water resources
46%

Water resources
46%
Electrical
4%

Buildings and
Industrial
19%

Transportation
27%

Strong buildings segment revenue


contribution versus backlog
contribution of 19%

Buildings and
Industrial
24%

Transportation
12%

Low revenue contribution


from roads segment
versus backlog share

Source: Company, Kotak Institutional Equities

Recently signed concession agreements for two BOT projects; Goa still remaining
The company has signed concession agreements for two of the three recent BOT project
wins viz. (1) Rs15 bn Sion-Panvel expressway (won in Sept-2010- financial closure likely to
happen soon) and (2) Rs7.5 bn Karanji-Wani-Ghuggus-Chandrapur road (won in Sept-2010
financial closure likely to happen soon). The Rs31 bn Maharashtra-Goa project (won in
June-2010) is still awaiting concession agreement and financial closure.
Sion-Panvel and Karanji-Chadrapur concession agreements signed in 3QFY11
Key details of existing and recent BOT project wins of IVRCL
Sion-Panvel
Expressway
Concession agreement yet to be signed
25 kms of a 10-lane
concrete expressway from
Sion to Panvel
Project Description
Company's share
51%
Other partners
Kakade Infra.

4 laning of Karanji - Wani


- Ghuggus - Chandrapur
highway
100%
NA

4/6 laning of 122 km


from Mah/Goa border to
Goa/Kar border
100%
NA

Project Type
Concession Period
Construction period

Toll
30 years
2 years

Toll
23 years
3 years
Positive grant of
Rs6,647.2 mn

Toll
18 years and 9 months

Grant structure

No grant
Concession agreement
signed, financial closure
expected soon
Project status
Estimated Funding structure (in Rs mn)
Total project Cost
14,500
Equity
3,000
Debt
7,600
Grant
3,900
IVRCL's Equity Commitment
1,530

Karanji - Wani Mah/Goa border to


Ghuggus - Chandrapur Goa/Kar border

Rs2,318.4 mn VGF
Concession agreement
signed, financial closure
expected soon
7,500
1,295
3,886
2,318
1,295

Concession agreement to
be signed
31,000
7,170
6,647
2,318
7,170

Source: Company, Kotak Institutional Equities

KOTAK INSTITUTIONAL EQUITIES RESEARCH

17

Construction

IVRCL

Construction work has begun on several financially closed BOT projects including BaramatiPhaltan, Chengapalli- Walayar and Indore-Gujarat.
Key details of completed and financially closed BOT projects of IVRCL
JallandharAmristar
Completed/ Financially closed projects
4 laning of 49 km
JallandharProject Description
Amristar stretch
Company's share
100%
Other partners

Project Type
Concession Period
Construction period
Grant structure

Toll
17.5 years
2.5 years
Positive grant of
Rs 330 mn

Project status
Operational
Estimated Funding structure (in Rs mn)
Total project Cost
3,430
Equity
671
Debt
2,365
Grant
395
IVRCL's Equity
671

Salem Kumarapalayam

Kumarapalayam
Chenagmpalli

Chennai
Water

BaramatiPhaltan

47 km from
53 km from Salem Kumarapalayam to
to Kumarapalayam Chengapalli
100 MLD
100%
100%
75%
Befesa

Chengapalli Indore-Gujarat Walayar

IOCL-tankage

4-laning of 78 km
Baramati-Phaltan- Construction of
Shirwal
12 tanks
75%
37.5%

155 km Indore
to Gujarat/MP
border
100%
NA

6-lanning of 42
km ChengapalliWalayar stretch
100%
NA

Two part
Toll
tariff
20 years
3 years
Positive grant of Rs
1290 mn

Toll
25 years

Annuity - (Rs350
mn per month)
Toll
15 years
27 years

Positive grant of
Rs1,220 mn

No grant

Rs230 mn
revenue share

Operational

Operational

Operational

25-27%
construction
completed

65%
construction
completed

Financial closure 7% construction


achieved
completed

5,020
800
2,930
1,290
800

4,215
650
3,390
175
650

5,680
1,730
3,950

3,820
700
1,900
1,220
525

30,000
2,250
2,250 -Sponser
25,500 - Senior
844

15,200
3,800
11,400

3,800

Toll
20 years
2 years
Positive grant of Rs
175 mn

1,297

Toll
25 years
Rs360 mn
revenue share

11,250
4,250
7,000

4,250

Source: Company, Kotak Institutional Equities

Order inflows just keeping pace; current backlog and its execution holds the key
The company reported an order backlog of Rs242 bn at end- 3QFY11 leading to an order
booking of about Rs16 bn in this quarter. The order backlog provides a revenue visibility of
about 3.4 years based on forward four quarter revenues.
Order book visibility at about three years based on forward four quarter revenues
Order backlog, booking and visibility (X) of IVRCL Infrastructure, March fiscal year-ends, 2002-3QFY11

Order Backlog (LHS)

(Rs bn)
280

Order Booking (LHS)

Visibility (RHS)

(years)
3.8

3Q11

2Q11

1Q11

4Q10

3Q10

2Q10

1Q10

4Q09

3Q09

2Q09

0.2
1Q09

40
4Q08

0.8

3Q08

80

2Q08

1.4

1Q08

120

FY07

2.0

FY06

160

FY05

2.6

FY04

200

FY03

3.2

FY02

240

(0.4)

Source: Company, Kotak Institutional Equities estimates

18

KOTAK INSTITUTIONAL EQUITIES RESEARCH

IVRCL

Construction

Reduced full-year revenue guidance of Rs62.5 bn requires strong growth in 4Q


The management reduced the FY11 revenues guidance to Rs62.5 bn vs. earlier guidance of
Rs67.5-71 bn. The present guidance still implies 4QFY11 revenue of Rs26.5 bn and a strong
yoy growth of 35.6%. We highlight that the company had booked revenues of Rs18.9 in
4QFY10 which was the strongest quarter in the year.
We have built in revenues of Rs58.2 bn implying 17% yoy growth in 4QFY11E. Our full-year
margin assumption of 9.5% implies an EBITDA margin requirement of 9.8% in 4QFY11E
relatively flat on a yoy basis. Full-year PAT of Rs2 bn implies a net PAT of Rs930 mn in
4QFY11E versus Rs850 mn in 4QFY10.
IVRCL - 4QFY11E - implied key numbers (Rs mn)

Net Sales
Expenditure
EBITDA
Other income
Interest
Depreciation
PBT
Tax
PAT
Order book
Order booking
Key ratios (%)
EBITDA margin
PBT margin
Net PAT margin
Effective tax rate

9MFY11 9MFY10 % chg.


36,002
35,386
1.7
(32,637) (32,130)
1.6
3,365
3,255
3.4
76
135
(43.5)
(1,525)
(1,115)
36.8
(540)
(401)
34.7
1,376
1,874
(26.6)
(440)
(608)
(27.8)
937
1,265
(26.0)

9.3
3.8
2.6
31.9

NA

9.2
5.3
3.6
32.5

4QFY11E
22,262
(20,092)
2,170
60
(625)
(190)
1,415
(487)
928

4QFY10 % chg.
19,537
13.9
(17,480)
14.9
2,058
5.5
20
202.4
(523)
19.5
(142)
34.1
1,412
0.2
(569)
(14.4)
844
10.0

FY2011E
58,265
(52,730)
5,535
136
(2,150)
(730)
2,791
(927)
1,864

FY2010 % chg.
54,923
6.1
(49,610)
6.3
5,313
4.2
155
(12.0)
(1,639)
31.2
(543)
34.5
3,286
(15.1)
(1,177)
(21.3)
2,109
(11.6)

NA

98,501

103,556

98,501

9.7
6.4
4.2
34.4

10.5
7.2
4.3
40.3

9.5
4.8
3.2
33.2

9.7
6.0
3.8
35.8

NA

5.1

Source: Company, Kotak Institutional Equities

Needs Rs13.5 bn of equity funding for road projects; may sell equity stake in
BOT projects
Present portfolio of IVRCL Assets BOT projects requires incremental equity of about Rs13.5
bn. Delays/difficulties in raising this equity would potentially lead to lower construction
revenues and/or may put stress on the standalone balance sheet. Funds up to Rs6.5 bn are
already tied up through (1) issue of compulsorily convertible debentures of Rs2.5 bn to IFCI
and (2) investment from UTI for about Rs1.5 bn and (3) issue of NCDs for a total of about
Rs2.5 bn. The rest are to be funded from stake sale of existing and upcoming BOT projects,
land sales etc. IVRCL Infrastructure as a parent entity is not envisaged to invest in equity of
BOT projects help in IVR Prime.

Debt and working capital remain stable on a qoq basis


IVRCL management indicated net debt at end-Dec 2010 of about Rs22 bn versus Rs21.2 bn
at end-Sept 2010 and Rs15.5 bn at FY2010-end level. The increase in debt levels was
primarily due to higher loans & advances to subsidiaries for investment in the BOT assets.
Loans and advances towards subsidiaries stood at about Rs4.5 bn versus end-FY2010 level
of about Rs2.8 bn. We have built in debt levels of about Rs23 bn at end-FY2011E.

KOTAK INSTITUTIONAL EQUITIES RESEARCH

19

Construction

IVRCL

Revise earnings estimates and target price to Rs125/share; retain BUY


We have revised our FY2011E, FY2012E and FY2013E estimate to Rs7 (Rs7.7 earlier), Rs8.9
(Rs10.3 earlier) and Rs12.6 (Rs15.7) earlier primarily based on higher interest cost versus
earlier estimates. We have revised our target price to Rs125 from Rs190 earlier based on (1)
using 10X multiple now versus 13X earlier (Rs30 impact on the target price), (2) lower
valuation of listed subsidiaries IVR Prime and Hindustan Dorr Oliver (Rs20 impact on the
target price) and (3) reduction in earnings estimates (Rs20 impact on the target price).
Revised estimates for IVRCL, March fiscal year-ends, 2011E-12E (Rs mn)

Revenues
EBIDTA
EBITDA margin (%)
PAT
EPS (Rs)
yoy growth (%)
Revenus
EBITDA
PAT
EPS

New estimates
FY2011E
FY2012E
58,265
72,655
5,535
6,902
9.5
9.5
1,864
2,389
7.0
8.9

6.1
4.2
(11.7)
(11.7)

24.7
24.7
28.1
28.1

Old estimates
FY2011E
FY2012E
58,664
74,642
5,573
7,091
9.5
9.5
2,063
2,759
7.7
10.3

6.8
(42.4)
(2.3)
(2.3)

% revision
FY2011E
FY2012E
(0.7)
(2.7)
(0.7)
(2.7)
(9.6)
(9.6)

(13.4)
(13.4)

27.2
(38.0)
33.7
33.7

Source: Company estimates, Kotak Institutional Equities estimates

We retain BUY as (1) execution of road projects may pick up as part of equity gets tied up,
and agreements and financial closures are completed, (2) attractive valuation 4X FY2012E
P/E adjusted for equity holdings in IVR Prime and HDO, (3) order book visibility.

20

KOTAK INSTITUTIONAL EQUITIES RESEARCH

IVRCL

Construction

Key order booking and execution segmental assumptions for IVRCL (standalone), March fiscal
yearends,2008-13E (Rs mn)

IVRCL Construction
Orders received
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio
Segmental
Water resources and irrigation
Orders received
Growth (%)
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio
Transportation
Orders received
Growth (%)
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio
Buildings
Orders received
Growth (%)
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio
Electrical
Orders received
Growth (%)
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio

2008

2009

2010

2011E

2012E

2013E

87,967
36,622
59.5
122,415
31.8

63,229
48,819
33.3
136,825
31.7

136,175
56,000
14.7
217,000
27.3

103,556
58,265
4.0
262,292
21.7

101,252
72,655
24.7
290,889
23.2

116,340
92,542
27.4
314,688
26.5

58,272
181.1
17,824
52.0
75,728
27.7

44,209
(24.1)
25,874
45.2
94,063
26.4

39,937
(9.7)
26,000
0.5
108,000
22.8

39,937
25,594
(1.6)
122,343
20.0

39,937
32,020
25.1
130,260
22.5

45,927
15.0
38,306
19.6
137,881
25.0

440
(80.3)
6,933
115.3
11,157
38.8

1,583
259.9
6,346
(8.5)
6,394
53.1

53,606

7,000
10.3
53,000

32,164
(40.0)
8,635
23.4
76,528

25,731
20
13,409
55.3
88,850

21.1

12.5

15.0

29,591
15.0
23,320
73.9
95,121
22.5

25,410
445.9
6,935
77.4
28,015
31.2

12,304
(51.6)
10,252
47.8
30,067
30.0

15,933
29.5
11,000
7.3
35,000
28.9

17,526
10.0
14,661
33.3
37,866
33.5

20,155
15.0
15,582
6.3
42,439
32.5

23,178
15.0
17,559
12.7
48,058
32.5

3,845
(58.8)
4,930
20.2
7,515
46.9

5,132
33.5
6,346
28.7
6,301
63.0

12,700
147.5
5,000
(21.2)
14,000
39.5

11,430
(10.0)
6,900
38.0
18,529
35.0

11,430

8,485
23.0
21,473
35.0

13,144
15.0
9,816
15.7
24,802
35.0

Source: Company, Kotak Institutional Equities

We correspondingly revise our SOTP-based target price to Rs125/share from Rs190/share.


Our target price of Rs125/share is comprised of (1) Rs90/share from the core construction
business based on 10XFY2012E earnings, (2) IVRCL Assets contribution of Rs26/share, and
(3) Rs10/share contribution from Hindustan Dorr Oliver.
We arrive at an SOTP-based target price of Rs125/share for IVRCL

Project/ Business
Value of core construction business
Value of Hindustan Dorr Oliver
Value of IVRCL Prime Developers Ltd
Total

Valuation
(Rs mn) Rs/ share
24,156
89
2,697
10
6,921
26
125

Valuation methodology
# P/E multiple of 10X FY2012E earnings
# Discount to market price
# Discount to market price
#

Source: Company, Kotak Institutional Equities estimates

KOTAK INSTITUTIONAL EQUITIES RESEARCH

21

Construction

IVRCL

Profit model and balance sheet of IVRCL, March fiscal year-ends, 2007-13E (Rs mn)
2007

2008

2009

2010E

2011E

2012E

2013E

Income statement
Operating Income
Operating Expenses
EBITDA
Other Income
Interest & Finance charges
Depreciation
Profit Before Tax
Tax expense
PAT
EPS (Rs)

23,059
(19,497)
2,301
74
(308)
(216)
1,851
(436)
1,415
10.9

36,606
(30,965)
3,544
45
(407)
(328)
2,853
(749)
2,105
15.8

48,819
(41,772)
4,145
299
(1,233)
(473)
2,738
(478)
2,260
16.9

54,923
(46,281)
5,313
155
(1,637)
(543)
3,288
(1,177)
2,111
7.9

58,265
(49,525)
5,535
136
(2,150)
(730)
2,791
(927)
1,864
7.0

72,655
(61,975)
6,902
148
(2,611)
(863)
3,576
(1,187)
2,389
8.9

92,542
(78,938)
8,791
160
(2,913)
(1,007)
5,032
(1,671)
3,361
12.6

Balance sheet
Total share holders funds
Share Capital
Reserves & Surplus
Loan Funds
Working Capital Loan
Long term
Total Sources of Funds
Net fixed assets
Net block
Capital WIP
Investments
Net Current Assets (excl Cash)
Cash and Bank Balances
Total

13,217
259
12,918
5,561
2,864
1,580
18,834
2,435
1,929
506
2,829
11,332
2,238
18,834

16,060
267
15,789
10,678
5,215
5,159
26,841
3,733
3,192
541
3,409
17,928
1,772
26,841

18,106
267
17,839
13,980
7,645
3,949
32,203
5,403
5,207
196
3,892
21,900
1,009
32,203

18,533
534
17,999
16,133
9,103
3,489
34,791
6,017
5,664
353
6,138
20,992
1,644
34,791

20,276
534
19,742
22,883

22,542
43,159
6,684
6,434
250
5,910
27,381
3,184
43,159

22,544
534
22,010
24,883

24,542
47,427
7,321
7,071
250
6,210
30,989
2,907
47,427

25,784
534
25,250
27,383

27,042
53,168
8,064
7,814
250
6,210
35,139
3,755
53,168

Free cash flow


Net cashflow from operating activites
Net PBT
Add: Depreciation
Add: Financial Charges
Tax paid
Change in wcap.
Cash flow from investing activities
Free cash flow

(4,340)
1,851
216
308
(399)
(6,316)
(1,407)
(5,747)

(3,657)
2,853
328
407
(650)
(6,596)
(2,264)
(5,922)

22
2,738
473
1,233
(449)
(3,972)
(2,611)
(2,589)

5,213
3,288
543
1,637
(1,162)
908
(5,087)
127

(1,769)
2,791
730
2,150
(1,051)
(6,390)
(1,169)
(2,938)

2,255
3,576
863
2,611
(1,187)
(3,608)
(1,800)
455

3,131
5,032
1,007
2,913
(1,671)
(4,150)
(1,750)
1,381

10.0
6.1
0.4
0.3
15.7
10.7

9.7
5.7
0.7
0.6
14.4
10.4

8.5
4.6
0.8
0.7
13.2
10.5

9.7
3.8
0.9
0.8
11.5
9.6

9.5
3.2
1.1
1.0
9.6
8.5

9.5
3.3
1.1
1.0
11.2
9.1

9.5
3.6
1.1
0.9
13.9
10.6

Key ratios
EBITDA margin (%)
PAT margin (%)
Debt/ equity (X)
Net debt/ equity (X)
ROAE (%)
ROACE (%)

Source: Kotak Institutional Equities

22

KOTAK INSTITUTIONAL EQUITIES RESEARCH

REDUCE

Jubilant Life Sciences (JOL)


Pharmaceuticals

FEBRUARY 16, 2011


RESULT, CHANGE IN RECO.
Coverage view: Cautious

Disappointing quarter. While sales were in line, EBITDA margin at 15.4% was down
350 bps qoq and below our est. of 18% due to (1) steep margin dip in services business
and (2) sequential decline of around 150 bps in margin of products business (80% of
sales) which is perplexing, given (1) 7% qoq increase in its sales, (2) sequential
improvement in selling pricing and (3) adequate raw material inventory. We cut our
FY2011-12E est. by 16-30% to account for (1) acute margin pressure the business is
facing and (2) poor revenue generation (5% in 9MFY11 excl. one-time H1N1 business
last year) and (3) increase in interest cost on account of FCCB repayment in May 2011E.
We downgrade to REDUCE with PT of Rs220 (from Rs350), 13X FY2012E.

Price (Rs): 193

Company data and valuation summary


Jubilant Life Sciences
Stock data
406-185
52-week range (Rs) (high,low)
Market Cap. (Rs bn)
30.7
Shareholding pattern (%)
Promoters
47.3
FIIs
25.5
MFs
5.9
Price performance (%)
1M
3M
12M
Absolute
(25.1) (36.4) (39.9)
Rel. to BSE-30
(22.7) (29.3) (47.2)

QUICK NUMBERS
Forecasts/Valuations
EPS (Rs)
EPS growth (%)
P/E (X)
Sales (Rs bn)
Net profits (Rs bn)
EBITDA (Rs bn)
EV/EBITDA (X)
ROE (%)
Div. Yield (%)

2010
26.5
49.0
7.3
37.8
4.5
8.3
6.6
26.3
1.0

2011E
14.6
(45.1)
13.3
34.5
2.6
5.8
10.1
11.9
1.0

2012E
16.9
15.9
11.4
38.7
2.7
7.0
8.2
12.1
1.3

3QFY11 revenues up 2% qoq, in line with our estimate


Sales at Rs8.7 bn were in line with our estimate with (1) services business (19% of sales)
underperforming, down 14% qoq due to delay in customer approvals in CMO business and delay
in milestone fees and (2) products business of lifecycle ingredients/generics was higher than our
est. by 5% and up 13% yoy with volume growth at 17%, indicating pricing pressure still remains
despite price improvement sequentially.

Target price (Rs): 220


BSE-30: 18,274

We downgrade to
REDUCE with PT of
Rs220 (from Rs350),
13X FY2012E
3QFY11 revenues,
up 2% qoq, in line
with our estimate
EBITDA margin at
15% was lower
than our estimate
of 18% and down
360 bps qoq

EBITDA margin at 15% was lower than our estimate of 18% and down 350 bps qoq
EBITDA margin excluding other income was down 350 bps qoq to 15% on account of (1) negative
margin in services business in 3QFY11 versus 2.6% in 9MFY11 due to postponement of milestone
income and (2) lower margin in products business at 22.8% in 3QFY11 versus 23.3% in 9MFY11,
implying that pricing pressure in pyridine and chemicals business still remains. This is despite this
business witnessing (1) 7% qoq increase in sales, (2) sequential improvement in selling pricing and
(3) adequate raw material inventory.
We cut our FY2011-12E est. by 16-30%
We cut our FY2011-12E est. by 16-30% to account for (1) acute margin pressure faced by the
services business. Our analysis shows EBITDA margin in services business excl. high-margin contract
of H1N1 was 10-12% in 9MFY10 which has collapsed to 3% in 9MFY11. We believe steady state
margin of 16-18% outlined by Jubilant is contingent upon healthy revenue generation, which has
not been seen YTD, with DDDS facing sales dip of 20% in 9MFY11 and sequential decline in CMO
business in 3QFY11, (2) poor revenue generation (5% in 9MFY11 excl. one-time H1N1 business)
and (3) increase in interest cost on account of inc. in debt to repay FFCB in May 2011E.
We downgrade to REDUCE from BUY with PT of Rs220 (from Rs350), 13X FY2012E
We believe the key revenue drivers are some time away(1) new launches in APIs, the two major
sartans Jubilant has filed DMF for expire only in 2012E and (2) revenue generation from capacity in
pyridines is likely in 2HFY12-13E.

For private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.

Pharmaceuticals

Jubilant Life Sciences

Interim results- Jubilant, March fiscal year-ends (Rs mn)

Net sales
Change in stock
Cost of trading goods sold
RM consumed
Stores, spares
Mfg exp
Staff cost
Selling exp
Exchange loss/(gain)
Total Expenditure
EBITDA
EBITDA, %
Other income
Interest
Depreciation
PBT
Tax
PAT
Minority interest
PAT before exceptional
Exceptional item
PAT
Lifescience ingredients
Generics
CMO
Drugs discovery & development
Hospitals
Total

3,102
549
710
1,790
870
(570)
6,450
2,200
25.4
100
390
310
1,600
200
1400
30
1,370
(420)
950

2QFY11
8,500
(95)
499
2,778
522
673
1,789
756
7
6,929
1,571
18.5
73
221
488
934
42
892
(5)
897
(7)
891

3QFY11E
1
NM
NM
(18)
11
2
(4)
23
NM
6
(17)
(3)
(58)
(5)
(1)
(36)
(17)
(39)
NM
(38)
NM
(41)

% change
3QFY10
0
NM
NM
(14)
4
(1)
(1)
(3)
NM
14
(41)
(10)
(58)
(27)
59
(65)
(46)
(68)
NM
(66)
NM
(54)

2QFY11
2
NM
46
(4)
9
4
(1)
11
NM
6
(17)
(4)
(43)
29
1
(40)
158
(49)
NM
(49)
NM
(50)

5,240
950
1,750
690
20
8,650

5,470
1,100
1,390
510
30
8,500

5
5
(17)
(1)
(17)
1

11
24
(34)
(29)
25
0

6
7
(17)
(4)
(17)
2

3QFY11
8,665
107
729
2,681
568
700
1,777
843
(35)
7,368
1,297
15.0
42
286
493
560
108
452
(8)
460
(19)
441

3QFY11E
8,553
3,250
513
684
1,850
684
6,982
1,571
18.4
100
300
500
871
131
740
(5)
745
745

3QFY10
8,650

5,820
1,180
1,150
490
25
8,665

5,517
1,121
1,391
493
30
8,553

Source: Kotak Institutional Equities estimates, Company

Revenue break-up (Rs mn)

LS Ingredients
Generics
Products
CMO
DDDS
Hospitals
Services
Total
Adjusted growth

9MFY10
15,630
2,820
18,450

9MFY11
16,600
3,270
19,870

%
6
16
8

FY2010
20,813
3,820
24,633

FY2011E
22,534
4,400
26,934

%
8
15
9

FY2012E
25,650
5,272
30,922

%
14
20
15

FY2013E
28,277
6,118
34,394

%
10
16
11

4,400
1,930
60
6,390

3,930
1,540
90
5,560

(11)
(20)
50
(13)

6,620
2,490
80
9,190

5,301
2,142
115
7,558

(20)
(14)
44
(18)

5,558
2,048
140
7,746

5
(4)
22
2

5,912
2,112
141
8,165

6
3
1
5

24,840
24,240

25,430
25,430

2
5

33,823
32,075

34,492
34,492

2
8

38,667
38,667

12
12

42,560
42,560

10
10

Source: Kotak Institutional Equities estimates, Company

24

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Jubilant Life Sciences

Pharmaceuticals

Sartans to add to revenues only from 2HFY12E

API
Esprosartan
Candesartan
Losartan
Valsartan
Olmesartan
Telmisartan
Irbesartan

Patent expiry
2014
Dec-12
4QFY11E
Sep-12
2016
2014
2011

Brand name
Teveten
Atancand
Hyzaar
Diovan
Benicar
Micardis
Avalide

Innovator
Abbott
Astrazeneca
Merck
Novartis
Daiichi
Boehringer
Sanofi

DMF filed
Y
Y
Y
Y
N
N
N

Genericised
N
N
Y
N
N
N
N

Source: US FDA

Debt and interest cost details (Rs mn)

FCCB
Debt in standalone (Rupee)
Debt in standalone (FC)
Debt in Sub (Rupee)
Debt in Sub (FC)
Gross debt
Cash
Net debt
Net debt/Equity
Interest cost calculation
Interest bearing debt (Rupee)
Interest bearing debt (FC)
Total interest bearing debt
Average interest rate (Rupee)
Average interest rate (FC)
Interest cost
Interest cost in P&L
Interest cost (%)

FY2009
9,750
9,331
6,190
600
12,910
38,781
6,530
32,251
2.5

FY2010
8,610
6,800
4,710
510
10,570
31,200
7,601
23,599
1.1

Sep-10
6,390
3,990
7,750
510
10,070
28,710
1,410
27,300
1.2

Dec-10
6,350
5,880
7,600
260
9,700
29,790
980
28,810
1.4

FY2011E
6,350
6,019
7,600
260
9,700
29,929
1,690
28,238
1.3

FY2012E
10,354
7,600
260
9,700
27,914
500
27,414
1.2

9,931
19,100
29,031

7,310
15,280
22,590
10.6%
3.8%
1,558
1,505
5.8%

4,500
17,820
22,320
8.9%
4.2%

6,140
17,300
23,440
9.0%
4.2%

4.9%

5.0%

6,279
17,300
23,579
8.9%
4.2%
1,292
1,028
4.4%

10,614
17,300
27,914
10.0%
4.5%
1,626
1,600
6.2%

Source: Kotak Institutional Equities estimates, Company

KOTAK INSTITUTIONAL EQUITIES RESEARCH

25

Pharmaceuticals

Jubilant Life Sciences

Profit and loss statement, March fiscal year-ends, 2008-2013E (Rs mn)

2008
2009
2010
2011E
2012E
2013E
Net sales
24,889 35,175 37,812 34,492 38,667 42,560
Operating expenses
Materials
(13,834) (18,461) (20,024) (15,713) (16,578) (17,927)
Selling and administration
(1,458) (1,805) (3,520) (5,979) (6,907) (7,180)
Employee cost
(3,670) (6,575) (7,453) (7,254) (8,342) (9,594)

R&D
(228)
(285)

Others
(1,420) (3,629)
1,070
50

Total expenditure
(20,382) (30,469) (29,926) (28,897) (31,827) (34,701)
EBITDA
4,507
4,706
7,886
5,595
6,840
7,858
Depreciation and amortisation
(1,039) (1,632) (1,247) (1,970) (2,200) (2,400)
EBIT
3,468
3,074
6,639
3,625
4,640
5,458
Net finance cost
(337) (1,070) (1,505) (1,028) (1,600) (1,800)
Other income
1,430
425
373
226
200
200
Pretax profits before extra-ordinaries
4,561
2,428
5,507
2,824
3,240
3,858
Current tax
(557)
(623)
(957)
(299)
(583)
(695)

Deferred tax
12
127

Fringe benefit tax


(28)
(28)

Reported net profit


3,988
1,904
4,550
2,525
2,657
3,164
Minority interests
16
133
(5)
29
32
35
Reported net profit after minority inter 4,005
2,037
4,545
2,553
2,688
3,199
Exceptional items
790
(331)
(233)

PAT after minority interests and excep.


4,005
2,827
4,214
2,320
2,688
3,199
Source: Kotak Institutional Equities estimates, Company

Balance sheet statement, March fiscal year-ends, 2008-2013E (Rs mn)

2008
Balance sheet
Net worth
Debt
Current liabilities
Deferred tax liabilities
Total equity and liabilities
Cash and cash equivalents
Current assets
Net assets incl CWIP
Investments
Total uses of funds

2011E

2012E

2013E

12,563 12,675 21,893 21,171


21,085 38,781 31,200 29,929
6,679 11,943 12,728 10,876
1,516
1,470
2,303
2,275
41,842 64,870 68,124 64,250
5,238
3,817
5,037
1,000
12,160 15,855 17,278 17,581
23,988 42,484 43,245 44,979
456
2,714
2,564
690
41,842 64,870 68,124 64,250

23,393
27,914
10,153
2,243
63,703
500
16,924
46,279

63,703

25,940
27,520
11,036
2,208
66,704
500
18,825
47,379

66,704

6,169
(160)
(3,500)
690
3,199

7,040
(1,205)
(3,500)

2,335

Free cash flow


Operating cash flow, excl. working 5,247
Working capital
(1,895)
Capital expenditure
(7,241)
Investments
(418)
Free cash flow
(4,306)

2009

4,218
1,553
(7,383)
(2,257)
(3,868)

2010

7,041
(752)
(2,011)
149
4,427

5,413
(2,157)
(3,704)
1,874
1,426

Source: Kotak Institutional Equities estimates, Company

26

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Kotak Institutional Equities: Valuation summary of key Indian companies


27
Company

15-Feb-11
Price (Rs)

Rating

Mkt cap.
(Rs mn)
(US$ mn)

O/S
shares
(mn)

2010

EPS (Rs)
2011E

2012E

EPS growth (%)


2010
2011E

2012E

2010

PER (X)
2011E

2012E

EV/EBITDA (X)
2010
2011E 2012E

Price/BV (X)
2010 2011E 2012E

Dividend yield (%)


2010 2011E 2012E

2010

RoE (%)
2011E

2012E

Target
price

Upside

(Rs)

(%)

ADVT-3mo
(US$ mn)

Automobiles
Ashok Leyland
Bajaj Auto

55

SELL

72,700

1,597

1,330

2.8

4.3

4.7

84.5

53.5

8.1

19.4

12.6

11.7

11.7

8.5

8.0

1.8

1.6

1.5

2.7

1.8

1.8

10.9

13.6

13.4

56

2.5

7.9

1,328

ADD

384,352

8,444

289

62.8

90.3

100.0

128.2

43.8

10.8

21.2

14.7

13.3

14.6

10.5

9.4

13.1

8.3

5.8

1.5

1.9

1.9

70.9

68.5

50.6

1,500

12.9

23.1

59.1

466.0

Bharat Forge

320

Hero Honda

1,517

Mahindra & Mahindra

668

239

0.7

12.4

19.7

(92.0)

1,705

11.3

7.7

4.9

3.6

3.0

6.1

8.5

16.4

405

26.4

4.1

REDUCE

ADD

302,945

6,655

200

111.8

97.8

109.8

73.9

(12.5)

12.3

13.6

15.5

13.8

8.2

9.5

8.0

8.4

6.3

4.8

2.0

2.0

2.0

59.0

45.0

39.5

1,485

(2.1)

34.0

BUY

410,891

76,593

9,027

1,683

615

35.1

42.8

47.7

133.6

22.1

11.6

19.1

15.6

25.8

14.0

16.2

13.4

23.9

10.9

9.6

5.1

3.8

3.1

1.3

1.4

1.5

30.0

27.6

24.5

800

19.8

35.9

Maruti Suzuki

1,237

BUY

357,295

7,849

289

86.4

78.4

91.8

105.0

(9.3)

17.0

14.3

15.8

13.5

7.5

8.0

6.6

3.0

2.5

2.1

0.5

0.4

0.5

23.3

17.4

17.3

1,460

18.1

9.8

Tata Motors

1,237

ADD

822,232

18,063

665

18.5

129.9

133.6

(141.1)

603.4

2.9

67.0

9.5

9.3

13.3

6.4

6.0

9.8

3.8

2.8

1.0

0.5

0.5

15.3

58.6

34.9

1,305

5.5

114.0

Automobiles

2,427,009

53,317

327.4

87.7

8.9

24.0

12.8

11.8

11.9

8.1

7.2

6.0

3.9

3.0

1.2

1.1

1.1

24.8

30.4

25.8

149

Cautious
BUY

72,168

1,585

485

21.6

25.9

28.0

60.1

20.2

8.2

6.9

5.7

5.3

1.6

1.4

1.1

3.4

4.0

4.4

26.0

25.8

23.4

190

27.7

4.7

1,275

BUY

516,516

11,347

405

62.1

81.7

99.9

22.7

31.6

22.3

20.5

15.6

12.8

3.2

2.8

2.4

0.9

1.2

1.5

19.2

19.1

20.1

1,600

25.5

58.3

83.7

108.0

Banks/Financial Institutions
Andhra Bank
Axis Bank

120.5

37.3

29.1

11.6

11.0

1.6

2.1

2.4

24.4

25.8

23.7

1,200

30.6

9.1

Bank of India

443

ADD

233,191

5,123

526

33.1

51.4

64.4

(42.1)

55.1

25.5

13.4

8.6

6.9

1.8

1.6

1.3

1.6

2.4

3.1

14.2

19.5

21.0

560

26.3

14.9

Canara Bank

Bank of Baroda

581

919

ADD

BUY

238,374

5,237

410

73.7

98.7

102.0

45.8

34.0

3.3

7.9

5.9

5.7

1.9

1.5

1.2

1.7

1.7

2.1

22.5

24.6

20.9

700

20.4

19.2

Corporation Bank

577

143

82.0

89.3

97.9

31.8

8.9

9.7

7.0

6.5

5.9

1.4

1.2

1.1

2.9

3.1

3.4

22.0

20.4

19.3

700

21.2

Federal Bank

385

ADD

65,839

1,446

171

27.2

34.3

44.5

(7.1)

26.3

29.7

14.2

11.2

8.6

1.4

1.3

1.2

1.3

1.6

2.1

10.3

11.9

14.0

450

16.9

5.9

HDFC

647

REDUCE

928,227

20,392

1,436

19.7

24.3

27.4

22.7

23.4

12.7

32.8

26.6

23.6

6.1

5.4

4.7

1.1

1.3

1.5

20.0

21.5

21.3

690

6.7

44.5

16.1

ADD

335,938

82,814

7,380

1,819

366

8.5

7.6

2.4

2.0

1.7

1.2

HDFC Bank

2,107

ADD

964,465

21,188

458

64.4

86.2

111.8

22.1

33.8

29.8

32.7

24.4

18.8

4.5

3.9

3.4

0.6

0.8

1.0

17.1

19.2

2,400

13.9

47.0

ICICI Bank

1,054

ADD

1,213,267

26,654

1,151

36.1

45.8

58.0

6.9

26.7

26.8

29.2

23.0

18.2

2.4

2.2

2.0

1.1

1.3

1.7

8.0

9.9

11.6

1,230

16.7

118.0

142

ADD

207,378

4,556

1,458

8.4

9.1

10.9

44.9

8.3

19.5

17.0

15.7

13.1

3.0

1.9

1.6

0.9

1.2

1.5

16.6

15.0

13.9

175

23.1

26.5

India Infoline

72

BUY

21,365

469

299

8.1

7.4

8.0

59.2

(9.0)

8.1

8.8

9.7

8.9

1.3

1.2

1.0

4.6

4.4

2.6

14.7

13.2

13.8

100

39.9

4.8

Indian Bank

218

ADD

93,883

2,062

430

35.1

37.9

43.5

25.5

8.1

14.6

6.2

5.8

5.0

1.4

1.2

1.0

3.0

3.1

3.6

24.1

21.7

21.0

320

46.5

2.9

Indian Overseas Bank

131

BUY

71,505

1,571

545

13.0

17.6

24.1

(46.7)

35.3

37.1

10.1

7.5

5.5

1.1

1.0

0.9

2.7

2.9

3.2

9.6

12.1

14.9

180

37.1

J&K Bank

773

ADD

37,482

823

48

105.7

123.5

136.6

25.0

16.9

10.6

7.3

6.3

5.7

1.3

1.1

1.0

2.8

3.3

3.7

18.2

18.5

17.8

850

10.0

1.0

LIC Housing Finance

191

ADD

90,525

1,989

475

13.9

19.3

21.4

11.5

38.5

10.9

13.7

9.9

8.9

2.8

2.2

1.9

1.6

2.2

2.4

23.6

24.6

22.8

206

8.1

74.7

IDFC

Oriental Bank of Commerce


PFC
Punjab National Bank
Reliance Capital

345

ADD

86,549

1,901

251

64.9

25.3

30.5

9.8

7.6

5.8

5.3

1.2

1.0

0.9

2.6

3.4

3.8

14.5

16.9

16.4

450

30.3

8.7

262

REDUCE

300,773

6,607

1,148

20.5

24.1

28.2

54.0

17.5

17.0

12.8

10.9

9.3

2.4

2.0

1.8

1.7

1.8

2.2

19.0

19.3

19.5

300

14.5

4.1

BUY

345,240

7,584

315

123.9

138.2

166.1

26.4

11.5

20.3

8.8

7.9

6.6

2.1

1.7

1.4

2.0

2.6

3.1

26.2

23.9

24.0

1,500

37.0

9.7

ADD

118,600

2,605

246

13.1

6.6

17.0

(66.7)

(49.8)

159.7

36.8

73.4

28.3

1.7

1.7

1.6

1.3

0.5

1.4

5.0

2.3

5.9

600

24.5

26.3
20.8

1,095
482

45.3

59.1

3.6

Rural Electrification Corp.

243

REDUCE

239,491

5,261

987

20.3

25.5

29.2

23.2

25.9

14.5

12.0

9.5

8.3

2.2

1.9

1.6

2.7

3.2

3.6

22.0

21.2

21.2

275

13.4

Shriram Transport

712

ADD

158,842

3,490

223

39.2

55.8

65.9

30.1

42.5

18.1

18.2

12.8

10.8

4.3

3.6

3.0

1.7

2.4

2.8

28.4

29.3

28.7

800

12.4

7.3

SKS Microfinance

640

REDUCE

47,124

1,035

74

26.9

24.2

36.5

61.1

(10.3)

50.9

23.7

26.5

17.5

5.0

2.5

2.2

21.7

12.6

13.5

700

9.5

15.9

SREI

5,105

112

116

8.3

7.9

9.9

17.8

(4.8)

25.8

5.3

5.6

4.4

12.3

3.8

BUY

1,737,547

38,171

635

144.4

175.2

225.2

0.5

21.3

28.6

19.0

15.6

12.2

2.6

2.3

2.0

1.1

1.2

1.2

14.8

15.8

17.7

3,400

24.2

213.3

341

BUY

172,296

3,785

505

41.1

40.9

53.8

20.2

(0.4)

31.6

8.3

8.3

6.3

2.0

1.6

1.3

1.6

1.6

2.1

26.2

21.4

23.3

420

23.1

5.3

Yes Bank

277

340

15.0

21.4

26.4

370

33.5

23.0

State Bank of India

44

Banks/Financial Institutions

BUY
Attractive

94,173

2,069

8,546,127

187,744

0.4

0.4

0.4

2.7

2.7

2.7

11.1

10.5

46.7

42.4

23.5

18.5

13.0

10.5

3.0

2.5

2.1

0.5

0.8

1.0

20.3

21.3

21.7

15.0

24.2

20.9

16.9

13.6

11.3

2.6

2.3

2.0

1.3

1.5

1.8

15.5

16.6

17.4

Cement
ACC

1,003

SELL

188,444

4,140

188

83.2

51.7

54.5

47.9

(37.9)

5.4

12.0

19.4

18.4

6.4

8.9

7.2

3.0

2.8

2.5

2.7

2.3

2.3

29.3

16.4

15.8

920

(8.3)

10.3

Ambuja Cements

119

SELL

181,467

3,987

1,522

8.0

7.9

7.9

11.4

(0.7)

(0.1)

14.9

15.0

15.0

8.2

7.9

7.0

2.6

2.3

2.1

1.6

1.7

1.9

19.3

16.8

15.0

108

(9.4)

4.9

Grasim Industries

2,309

ADD

211,671

4,650

92

301.0

224.3

261.1

26.1

(25.5)

16.4

7.7

10.3

8.8

4.6

5.3

4.1

1.7

1.5

1.3

1.4

1.5

1.5

22.9

15.4

15.7

2,600

12.6

India Cements

93

SELL

28,629

629

307

10.0

3.0

6.8

(43.5)

(70.5)

130.5

9.3

31.5

13.7

5.4

9.4

6.4

0.7

0.7

0.7

2.3

3.4

3.4

8.2

2.3

5.3

85

(8.8)

2.4

Shree Cement

1,641

REDUCE

57,161

1,256

35

208.0

84.0

161.7

19.0

(59.6)

92.6

7.9

19.5

10.1

3.9

6.7

3.7

3.1

2.8

2.3

0.6

0.6

0.6

48.0

15.2

25.0

1,680

2.4

0.6

946

REDUCE

259,226

5,695

274

88.2

42.3

79.7

1,030

8.9

6.9

Neutral

926,597

20,356

UltraTech Cement
Cement

Source: Company, Bloomberg, Kotak Institutional Equities estimates

12.0

(52.1)

88.6

10.7

22.4

11.9

12.5

10.0

5.8

4.8

2.2

1.8

0.3

0.4

0.4

25.9

11.9

19.3

19.3

(24.7)

31.2

12.1

16.0

12.2

6.4

7.4

5.4

2.5

2.0

1.7

1.4

1.4

1.4

20.6

12.3

14.2

3.3

KOTAK INSTITUTIONAL EQUITIES RESEARCH

India Daily Summary - February 16, 2011

NR

2,737

Union Bank

Kotak Institutional Equities: Valuation summary of key Indian companies


15-Feb-11
Price (Rs)

Rating

Mkt cap.
(Rs mn)
(US$ mn)

O/S
shares
(mn)

2010

EPS (Rs)
2011E

2012E

EPS growth (%)


2010
2011E

2012E

2010

PER (X)
2011E

2012E

EV/EBITDA (X)
2010
2011E 2012E

Price/BV (X)
2010 2011E 2012E

Dividend yield (%)


2010 2011E 2012E

2010

RoE (%)
2011E

2012E

Target
price
(Rs)

Upside
(%)

ADVT-3mo
(US$ mn)

Consumer products
Asian Paints
Colgate-Palmolive (India)
Dabur India
GlaxoSmithkline Consumer (a)

2,588

ADD

248,231

5,453

96

71.5

82.6

100.4

85.3

15.5

21.5

36.2

31.3

25.8

22.3

19.6

15.9

15.5

12.3

9.9

1.0

1.4

1.7

51.8

44.9

43.5

3,000

15.9

5.7

822

SELL

111,786

2,456

136

31.1

31.0

36.0

44.2

(0.5)

16.2

26.4

26.5

22.8

21.6

19.8

17.2

34.3

29.6

25.6

2.4

2.8

3.3

156.1

119.7

120.3

800

(2.7)

2.8

93

ADD

160,309

3,522

1,731

2.9

3.2

3.8

28.1

11.7

17.9

32.0

28.6

24.3

24.1

19.8

16.5

16.9

11.7

9.1

1.1

1.2

1.4

57.4

49.0

42.7

110

18.8

5.0

2,088

ADD

87,822

1,929

42

55.4

71.9

84.1

23.6

29.8

17.1

37.7

29.1

24.8

21.2

18.3

15.7

9.8

9.2

7.5

0.9

2.4

1.3

27.9

32.4

33.0

2,400

14.9

1.0

Godrej Consumer Products

366

ADD

118,580

2,605

324

11.3

13.6

17.1

69.5

20.0

26.1

32.3

26.9

21.4

25.6

19.1

14.9

12.3

6.6

6.1

1.1

0.9

0.9

44.6

31.9

29.6

440

20.1

1.9

Hindustan Unilever

273

SELL

595,928

13,092

2,182

9.4

17.5

2.8

2.9

3.4

250

(8.5)

ITC

157

ADD

1,201,900

26,404

7,651

5.3

6.5

7.8

22.6

22.8

19.0

29.6

24.1

20.3

17.9

15.3

12.7

8.1

6.8

5.9

3.2

1.7

2.4

29.2

32.1

32.4

185

17.8

28.6

Jubilant Foodworks

499

SELL

31,871

700

64

5.6

11.5

14.5

347.1

104.4

26.3

88.9

43.5

34.4

47.6

25.8

17.5

27.1

16.7

11.3

47.3

47.6

39.1

450

(9.8)

13.4

Jyothy Laboratories

231

ADD

17,687

389

77

11.0

11.4

13.7

99.6

3.8

19.4

20.9

20.2

16.9

16.7

13.1

10.5

4.3

2.5

2.3

1.9

1.6

2.1

14.8

12.8

14.6

270

16.9

0.5

Marico

126

ADD

77,301

1,698

612

4.4

5.0

5.6

32.9

12.2

12.8

28.4

25.3

22.4

19.4

17.8

14.9

11.6

8.5

6.5

0.5

0.7

0.8

48.9

39.2

33.3

140

10.8

Nestle India (a)

11.4

(0.9)

2.2

17.9

29.0

28.4

24.0

19.8

20.5

17.4

23.1

20.1

71.1

75.9

77.8

15.7

2.3

REDUCE

327,057

7,185

96

74.4

88.4

108.0

27.0

18.8

22.1

45.6

38.4

31.4

30.2

25.8

21.3

56.3

43.9

33.9

1.4

1.8

2.2

136.0

128.5

121.8

3,100

(8.6)

2.4

96

ADD

59,212

1,301

618

6.1

5.2

5.9

14.5

(14.0)

14.2

15.8

18.4

16.1

7.5

8.1

7.3

1.2

1.2

1.1

2.1

1.8

2.1

10.2

8.4

9.1

110

14.9

2.9

Titan Industries

3,213

ADD

142,612

3,133

44

57.3

107.1

125.9

29.3

87.1

17.5

56.1

30.0

25.5

35.7

21.8

18.0

19.3

12.4

8.6

0.5

0.4

0.4

38.7

50.3

39.8

4,100

27.6

33.7

United Spirits

1,137

126

27.3

33.1

47.0

1,550

36.3

8.5

Tata Global Beverages

3,392

9.6

Consumer products

ADD
Cautious

142,857

3,138

3,323,151

73,004

49.9

21.5

41.9

41.7

34.3

24.2

16.1

15.0

12.3

3.8

3.4

3.0

0.2

0.2

0.3

9.8

10.5

13.3

24.8

17.4

19.7

32.2

27.4

22.9

20.0

17.7

14.7

10.0

8.3

7.2

2.1

1.8

2.1

31.0

30.2

31.3

Constructions
IVRCL

BUY

19,465

428

267

7.9

7.7

10.3

9.2

9.4

7.1

6.4

7.3

6.0

1.1

1.0

0.8

1.1

0.5

0.5

11.5

10.6

12.7

190

160.6

102

BUY

26,133

574

257

7.1

7.2

9.7

6.1

1.2

34.3

14.3

14.1

10.5

8.2

9.2

7.6

1.2

1.1

1.0

1.3

2.0

2.0

9.3

8.0

10.1

160

57.1

3.8

Punj Lloyd

73

REDUCE

24,620

541

340

(3.4)

1.3

8.5

(52.6)

(137.2)

567.0

(21.2)

56.9

8.5

17.3

8.4

5.9

0.8

0.8

0.7

0.2

0.1

1.0

(4.2)

1.4

9.0

90

24.1

11.1

Sadbhav Engineering

98

BUY

14,768

324

150

5.1

6.2

8.7

0.5

20.2

41.0

19.2

15.9

11.3

13.5

9.0

7.5

3.6

2.8

2.7

0.3

6.1

6.1

15.8

17.8

23.9

175

77.8

0.4

56.2

54.2

15.9

Nagarjuna Construction Co.

73

Construction

(6.6)

(2.3)

33.7

7.6

Attractive

84,986

1,867

79.0

24.8

16.1

9.0

10.2

8.4

6.5

1.1

1.1

1.0

0.8

1.8

2.1

4.5

6.6

10.8

Aban Offshore

586

BUY

25,488

560

44

106.6

104.6

107.6

10.0

(1.9)

2.9

5.5

5.6

5.4

7.8

6.5

6.4

1.1

1.2

1.0

0.6

0.6

0.7

24.3

26.1

20.4

815

39.1

Bharat Petroleum

604

BUY

218,334

4,796

362

57.6

52.9

49.5

224.5

(8.2)

(6.4)

10.5

11.4

12.2

6.1

6.3

6.5

1.6

1.4

1.3

2.3

2.7

2.7

14.6

12.4

10.7

740

22.5

11.2

Cairn india

322

RS

610,921

13,421

1,897

5.5

30.2

49.1

29.0

445.6

62.6

58.1

10.7

6.6

45.8

8.0

4.9

1.8

1.6

1.4

4.7

3.1

15.6

22.4

15.7

Castrol India (a)

410

SELL

101,348

2,226

247

15.4

21.0

21.7

44.6

36.2

3.5

26.6

19.5

18.9

15.7

12.1

11.5

22.0

20.9

19.8

3.0

4.1

4.3

83.8

109.9

107.9

390

(4.8)

0.8

GAIL (India)

458

ADD

580,393

12,750

1,268

24.8

29.4

37.4

11.7

18.8

27.3

18.5

15.6

12.2

10.4

9.3

8.2

3.2

2.8

2.4

1.6

2.0

2.5

17.4

18.1

19.8

540

18.0

14.3

98

REDUCE

55,007

1,208

562

7.3

8.5

8.6

232.7

16.8

0.9

13.4

11.5

11.4

6.9

7.0

6.5

3.2

2.6

2.2

1.0

2.2

3.5

27.1

24.9

21.1

90

(8.0)

4.0

Energy

GSPL
Hindustan Petroleum

353

BUY

119,620

2,628

339

51.6

46.3

39.5

204.2

(10.3)

(14.7)

6.8

7.6

8.9

2.4

2.6

2.6

0.9

0.8

0.8

3.4

4.1

3.5

13.1

10.6

8.3

490

38.9

10.1

Indian Oil Corporation

333

BUY

808,143

17,754

2,428

49.1

34.8

35.2

399.0

(29.2)

1.0

6.8

9.6

9.5

5.2

5.8

5.5

1.5

1.4

1.3

3.9

3.2

3.2

22.4

14.1

13.1

440

32.2

9.1

1,287

ADD

309,417

6,797

240

115.2

135.5

145.1

13.9

17.7

7.1

11.2

9.5

8.9

4.9

3.6

3.2

2.1

1.8

1.6

2.6

3.3

3.5

16.8

18.3

17.3

1,490

15.8

2.6

283

BUY

2,417,370

53,106

8,556

23.0

28.2

32.5

0.9

22.6

15.4

12.3

10.0

8.7

4.4

3.8

3.4

1.9

1.7

1.5

2.9

5.0

3.9

14.8

16.2

17.3

355

25.6

32.7

(22.0)

13.3

12.7

Oil India
Oil & Natural Gas Corporation
Petronet LNG

121

SELL

1,998

750

5.4

8.0

9.1

Reliance Industries

942

REDUCE

2,802,499

61,566

2,976

49.6

61.7

68.6

Neutral

8,139,477

178,811

Energy

90,938

19.7

105

(13.4)

6.1

24.2

11.2

19.0

15.3

13.7

9.7

7.4

6.3

1.9

1.7

1.5

0.7

0.9

1.1

11.4

12.9

12.9

990

5.1

125.6

34.7

18.1

15.0

13.5

11.5

10.0

6.8

5.7

4.9

1.9

1.7

1.5

1.9

2.6

2.7

13.8

14.8

15.2

190.2

(1.8)

48.9

13.8

22.5

15.1

9.1

8.4

3.6

3.0

2.6

1.4

2.1

2.5

15.9

20.4

Industrials
31.4

(35.2)

(35.4)

21.1

22.5

31.9

11.9

5.8

5.4

4.4

0.3

0.5

0.5

15.6

9.2

23.2

725

9.4

1.6

515

REDUCE

37,105

815

72

28.0

40.9

46.4

74.6

46.3

13.4

18.4

12.6

11.1

10.4

7.8

6.7

5.3

4.0

3.1

1.4

1.6

1.8

31.8

36.0

31.6

600

16.4

8.1

Bharat Electronics

ABB

1,685

REDUCE

134,832

2,962

80

96.1

105.6

120.1

(7.4)

9.9

13.7

17.5

16.0

14.0

8.1

7.1

5.9

3.0

2.6

2.3

1.1

1.5

1.5

17.5

17.6

17.6

1,800

6.8

1.6

Bharat Heavy Electricals

2,071

REDUCE

1,013,600

140.1

BGR Energy Systems

Crompton Greaves
Larsen & Toubro

663

REDUCE

140,400

3,084

212

16.7

10.8

37.7

22,267

490

87.9

115.5

267

BUY

171,024

3,757

642

12.8

14.4

16.2

46.5

12.0

12.5

20.8

18.5

16.5

12.0

10.6

8.9

6.8

5.2

4.1

0.5

0.7

0.8

37.9

31.9

27.8

310

16.3

7.1

ADD

983,299

21,601

605

57.9

74.9

86.0

15.6

29.2

14.9

28.0

21.7

18.9

16.0

11.8

10.2

4.4

3.6

3.1

0.8

0.7

0.9

18.6

18.4

17.7

1,850

13.9

66.1

23.6

17.9

14.8

12.9

10.1

8.2

6.4

5.0

4.0

0.9

1.2

1.4

29.8

31.3

30.2

2,400

15.9

32.8

Maharashtra Seamless

350

ADD

24,675

542

71

38.6

44.2

39.3

(10.9)

9.1

7.9

8.9

4.7

3.7

3.9

1.1

1.0

0.9

1.7

2.3

2.2

14.8

12.8

10.5

418

19.5

Siemens

838

REDUCE

282,591

6,208

337

22.4

27.4

33.2

39.5

21.9

21.3

37.4

30.6

25.3

20.0

18.3

14.8

8.7

7.2

5.9

0.6

0.7

0.8

25.2

25.6

25.5

735

(12.3)

9.5

48

REDUCE

76,419

1,679

1,594

(6.2)

(3.7)

3.5

(185.4)

(40.3)

(196.0)

(7.8)

(13.0)

13.6

13.6

17.0

7.5

1.1

1.1

1.1

0.4

(11.4)

(8.6)

7.9

45

(6.2)

25.9

Thermax

633

BUY

75,410

1,657

119

21.9

32.7

38.4

(9.6)

49.1

17.6

28.9

19.4

16.5

14.5

10.2

8.5

7.0

5.6

4.6

0.8

1.5

1.7

25.2

32.2

30.7

805

27.2

1.5

Voltas

177

331

10.9

10.6

12.1

57.4

200

13.1

4.5

Suzlon Energy

REDUCE

58,474

1,285

Cautious

2,997,829

65,857

Infrastructure
REDUCE

143,095

3,144

130

66.9

78.1

GMR Infrastructure

42

ADD

154,948

3,404

3,667

0.4

0.2

0.1

Gujarat Pipavav Port

Container Corporation

56

BUY

23,613

519

424

(3.7)

(1.3)

1.1

GVK Power & Infrastructure

1,101

60.5

29

BUY

45,481

999

1,579

1.0

1.3

1.5

IRB Infrastructure

175

BUY

58,047

1,275

332

11.6

13.5

12.3

Mundra Port and SEZ

142

2,017

3.3

4.2

6.7

Infrastructure

BUY

285,772

6,278

Cautious

710,956

15,619

Source: Company, Bloomberg, Kotak Institutional Equities estimates

28

India Daily Summary - February 1

Industrials

0.9

14.3

21.3

61.3

1,625

7.7

31.4

39.6

(2.1)
31.1

13.9

16.3

16.6

14.6

9.5

8.8

7.4

5.3

4.4

3.7

1.1

1.8

2.1

37.8

29.0

27.5

28.9

28.3

21.6

16.8

14.1

11.5

9.2

4.8

4.0

3.4

0.8

1.0

1.1

16.8

18.4

20.0

19.4

16.6

0.4

(0.6)

10.6

18.2

16.4

14.1

12.4

10.7

8.9

3.3

2.9

2.5

1.3

1.4

1.6

18.7

19.0

1,300

18.1

1.3

(43.7)

(49.4)

(55.8)

97.8

193.2

437.5

22.0

12.3

11.6

1.8

1.4

1.4

2.4

1.2

0.5

60

42.0

4.4

28.6

(64.8)

(186.1)

(15.0)

(42.8)

49.7

66.0

26.0

15.3

7.6

3.1

2.9

(75.1)

(9.7)

8.5

68

22.0

0.7

29.4

27.3

18.1

29.2

22.9

19.4

19.0

14.1

13.8

1.4

1.4

1.3

1.0

1.0

5.7

6.1

6.9

42

45.8

5.1

119.2

16.3

(8.8)

15.1

12.9

14.2

10.2

8.3

7.5

2.7

2.1

1.6

1.1

19.4

18.1

12.9

270

54.6

7.1

160

13.0

3.8

55.7

24.5

61.4

42.4

34.1

21.1

32.0

22.5

15.6

8.1

6.8

5.3

0.6

20.8

21.6

28.3

20.1

16.5

30.0

34.8

29.9

23.0

20.2

13.9

11.7

3.3

2.6

2.4

0.6

0.3

0.4

9.3

8.8

10.4

India Daily Summary - February 16, 2011

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Company

Kotak Institutional Equities: Valuation summary of key Indian companies


29
Company

15-Feb-11
Price (Rs)

Rating

Mkt cap.
(Rs mn)
(US$ mn)

O/S
shares
(mn)

2010

EPS (Rs)
2011E

2012E

EPS growth (%)


2010
2011E

2012E

2010

PER (X)
2011E

2012E

EV/EBITDA (X)
2010
2011E 2012E

Price/BV (X)
2010 2011E 2012E

Dividend yield (%)


2010 2011E 2012E

2010

RoE (%)
2011E

2012E

Target
price
(Rs)

Upside
(%)

ADVT-3mo
(US$ mn)

Media
DB Corp

239

BUY

43,388

953

182

10.6

12.6

14.0

286.5

18.8

10.8

22.5

18.9

17.1

12.5

10.6

9.7

6.7

5.5

4.7

0.8

1.7

2.5

40.3

31.8

29.7

325

36.1

0.3

64

ADD

67,656

1,486

1,062

(2.5)

(1.6)

0.2

(63.1)

(33.2)

(109.5)

(25.8)

(38.6)

408.3

74.4

30.8

14.8

16.9

30.1

28.0

234.3

(56.0)

7.1

66

3.6

5.2

155

ADD

11,356

249

73

2.5

7.9

10.0

NM

220.4

27.5

63.1

19.7

15.5

17.6

12.8

10.4

3.2

2.6

2.2

4.8

4.8

6.5

17.9

23.7

16.4

200

29.2

0.0

HT Media

145

ADD

34,134

750

235

6.1

7.0

8.5

623.3

15.4

21.0

23.8

20.6

17.0

12.3

9.3

7.5

3.4

2.5

2.3

0.2

1.4

2.8

15.3

13.8

13.9

170

17.0

0.3

Jagran Prakashan

117

BUY

35,295

775

301

5.8

7.0

7.9

92.0

19.2

13.4

20.1

16.8

14.8

12.0

9.8

8.8

5.8

5.2

4.7

3.0

3.4

4.3

30.0

32.4

33.4

155

32.3

0.5

DishTV
Hindustan Media Ventures

Sun TV Network

405

Zee Entertainment Enterprises

117

Media

3,510

394

13.1

18.3

22.7

ADD

114,420

2,514

978

5.3

4.8

6.2

Cautious

REDUCE

466,027

159,780

10,238

44.0
26.3
195.8

35.5

450

11.0

5.5

28.4

21.9

24.3

18.9

17.9

15.2

11.7

2.9

2.8

2.7

0.9

1.1

1.2

12.7

11.8

14.7

130

11.2

7.6

36.1

39.7

35.9

37.8

27.8

20.4

18.2

13.6

10.6

5.4

4.7

4.3

1.2

1.4

1.9

14.2

16.8

21.0

(9.7)

24.1

31.0

22.2

17.9

17.6

12.8

10.4

8.3

6.9

5.8

1.8

1.8

2.5

28.3

34.2

Metals & Mining


Coal India
Hindalco Industries
Hindustan Zinc

302

ADD

1,910,384

41,968

6,316

15.2

21.1

363.0

13.0

22.6

19.9

17.6

14.3

11.9

9.3

8.1

7.0

5.6

4.5

1.2

1.7

2.1

40.4

35.4

34.8

345

14.1

212

ADD

406,534

8,931

1,914

20.0

16.2

16.9

25.0

(18.8)

4.3

10.6

13.1

12.6

6.1

7.4

7.5

1.9

1.7

1.5

0.6

0.6

0.6

20.4

13.6

12.7

250

17.7

49.7

1,269

BUY

536,151

11,778

423

95.6

103.7

125.5

48.2

8.4

21.0

13.3

12.2

10.1

9.0

7.4

4.9

2.8

2.3

1.9

0.5

0.5

0.5

25.1

21.7

21.5

1,535

21.0

4.9

931

38.2

41.0

48.0

16.9

7.1

17.3

17.0

15.9

13.5

11.8

10.8

8.9

5.4

4.0

3.1

0.2

0.4

0.4

37.7

29.2

26.0

640

(1.7)

24.5
37.4

Jindal Steel and Power

651

REDUCE

606,001

13,313

JSW Steel

898

17.2

REDUCE

222,929

4,897

248

80.4

67.1

99.2

481.1

(16.5)

47.9

11.2

13.4

9.1

9.2

8.1

5.4

2.0

1.3

1.0

0.8

1.0

1.1

16.0

11.6

12.1

1,000

11.3

National Aluminium Co.

405

SELL

261,042

5,735

644

12.2

18.3

20.5

(37.2)

50.5

12.0

33.3

22.1

19.7

15.5

10.3

8.8

2.5

2.3

2.1

0.6

1.2

1.2

7.8

10.9

11.3

300

(26.0)

Sesa Goa

309

REDUCE

274,607

6,033

890

29.6

52.6

62.2

23.5

77.9

18.3

10.4

5.9

5.0

8.6

3.6

4.8

3.4

2.0

1.5

1.2

1.2

1.2

35.8

32.9

33.0

315

2.1

25.9

Sterlite Industries

164

BUY

549,631

12,074

3,362

12.0

13.0

19.4

2.8

8.0

49.4

13.6

12.6

8.4

8.7

7.2

4.4

1.5

1.3

1.2

0.6

0.6

0.6

12.9

11.2

14.8

200

22.3

26.2

Tata Steel

617

624,790

13,726

1,013

(3.3)

64.4

69.7

(103.6)

(2,051.8)

8.2

(186.8)

22.4

18.4

710

15.1

107.3

5,392,068

118,455

18.9

19.0

Metals & Mining

BUY
Attractive

9.4

36.3

21.3

18.1

9.6

8.8

11.9

6.5

5.9

2.7

1.8

1.5

1.1

1.2

13.3

10.9

10.0

7.8

6.5

3.2

2.5

2.1

0.8

1.1

1.1

(1.5)
17.7

0.6

Pharmaceutical
19.0

28.8

35.7

42.2

32.9

24.3

20.4

11.5

3.5

3.3

2.9

8.3

10.4

12.1

565

22.3

Biocon

336

ADD

67,230

1,477

200

14.8

18.3

22.7

216.4

23.4

24.2

22.7

18.4

14.8

13.1

9.9

8.2

3.8

3.2

2.7

17.9

19.3

20.5

445

32.4

5.5

Cipla

Apollo Hospitals

310

REDUCE

248,785

5,465

803

13.7

12.1

16.0

38.1

(11.9)

32.3

22.6

25.7

19.4

16.2

17.2

13.3

4.2

3.7

3.2

0.6

0.8

0.8

21.1

15.4

17.9

300

(3.2)

14.0

Cadila Healthcare

769

ADD

157,370

3,457

205

24.7

33.3

38.2

66.9

34.9

14.7

31.1

23.1

20.1

20.1

15.8

13.5

9.7

7.2

5.7

0.7

0.9

1.0

36.0

35.9

31.6

880

14.5

1.7

Dishman Pharma & chemicals

102

ADD

8,284

182

81

14.4

15.8

20.7

(19.7)

9.7

30.7

7.1

6.4

4.9

6.7

6.0

4.6

1.0

0.9

0.8

15.5

15.1

17.0

210

106.2

Divi's Laboratories

462

BUY

59,472

1,307

129

10.9

14.0

28.2

14.5

1.6

0.7

656

REDUCE

87,022

1,912

133

25.8

26.8

37.1

(19.2)

3.9

38.6

25.5

24.5

17.7

18.8

18.2

12.4

5.7

5.0

4.2

24.7

21.7

25.6

700

6.7

2.4

Dr Reddy's Laboratories

1,539

REDUCE

261,346

5,741

170

48.0

68.4

72.2

48.1

42.6

5.5

32.1

22.5

21.3

17.7

12.8

11.9

6.9

5.4

4.5

0.7

0.5

0.6

22.2

27.0

22.9

1,150

(25.3)

15.0

GlaxoSmithkline Pharmaceuticals (a)

18.4

15.9

10.5

29.7

2,000

(10.0)

2,222

REDUCE

188,236

4,135

85

59.1

70.2

79.6

8.1

18.7

13.5

37.6

27.9

21.8

Glenmark Pharmaceuticals

285

REDUCE

79,671

1,750

280

12.7

17.6

20.6

14.3

38.3

17.3

22.4

16.2

13.8

14.5

10.9

9.7

3.4

2.8

2.4

16.4

18.4

18.2

330

16.0

5.9

Jubilant Life Sciences

193

REDUCE

30,753

676

159

26.5

14.6

16.9

49.0

(45.1)

15.9

7.3

13.3

11.4

6.6

10.1

8.3

1.4

1.4

1.3

1.0

1.0

1.3

26.3

11.9

12.1

220

14.0

1.3

Lupin

423

ADD

188,086

4,132

445

15.3

17.6

22.4

27.3

15.0

26.9

27.6

24.0

18.9

23.1

19.8

15.4

7.3

5.9

4.7

0.7

0.8

1.1

34.1

27.3

28.0

465

9.9

15.1

Ranbaxy Laboratories

516

234.8

(39.4)

Sun Pharmaceuticals

424

SELL
ADD
Cautious

221,119

71.9

21.5

35.4

17.7

11.5

18.1

5.6

9.0

4.1

7.7

3.7

0.8

0.8

29.8

7.0

30.7

20.1

1.3

4,858

428

7.2

24.0

14.6

(128.9)

10.4

340

(34.1)

11.2

438,939

9,643

1,036

13.0

17.4

19.7

(25.7)

33.4

13.1

32.5

24.4

21.5

25.8

18.3

15.0

5.5

4.6

3.8

0.6

0.6

0.6

18.2

21.0

19.9

480

13.2

10.3

2,124,912

46,681

45.3

20.0

12.8

28.8

24.0

21.3

17.9

14.3

12.5

5.4

3.6

3.1

0.5

0.6

0.6

18.6

14.8

14.4

22.6

23.9

17.4

17.6

15.0

Property
DLF

240

ADD

410,940

9,028

1,714

10.6

10.0

13.8

12.4

1.4

1.3

1.2

0.9

1.2

2.1

6.6

5.5

7.3

265

10.6

46.5

Housing Development & Infrastructure

149

ADD

62,022

1,363

415

15.9

23.0

28.4

(24.4)

44.0

23.9

9.4

6.5

5.3

7.5

7.6

4.6

0.9

0.7

0.6

10.0

11.8

12.5

180

20.4

29.6

Indiabulls Real Estate

115

RS

46,277

1,017

402

(0.4)

3.1

8.5

(134.9)

(60.1)

(865.5)

(5.5)

178.9

37.3

(288.9)

37.7

13.5

(45.9)

52.3

15.5

0.4

0.4

0.4

(0.2)

1.0

2.9

21.4

Mahindra Life Space Developer

343

BUY

13,987

307

41

19.2

21.7

30.4

69.7

13.1

40.1

17.9

15.8

11.3

16.0

13.2

7.8

1.5

1.4

1.2

1.0

1.2

1.3

8.6

9.0

11.6

435

26.9

0.4

Oberoi Realty

228

BUY

75,084

1,649

330

13.7

18.7

24.9

57.1

36.9

32.7

16.6

12.2

9.2

14.6

7.9

5.1

4.0

2.2

1.8

0.1

0.4

0.7

27.7

23.3

21.5

305

33.9

1.0

Phoenix Mills

186

BUY

26,941

592

145

4.1

6.1

7.6

(16.7)

48.6

24.2

45.0

30.3

24.4

37.7

22.7

17.4

1.8

1.7

1.6

0.6

0.8

1.1

3.9

5.7

6.7

300

61.3

Puravankara Projects

105

REDUCE

22,506

494

213

6.8

7.3

8.8

0.6

7.6

19.9

15.5

14.4

12.0

18.0

16.3

11.7

1.6

1.5

1.3

1.9

1.9

1.9

10.5

10.5

11.6

100

(5.2)

0.1

Sobha Developers

242

BUY

23,682

520

98

14.1

18.8

24.0

(7.1)

33.4

27.9

17.2

12.9

10.1

14.3

10.7

8.2

1.4

1.2

1.1

0.4

0.5

0.7

9.7

10.1

11.7

380

57.3

1.7

35

RS

93,187

2,047

2,666

3.0

2.4

3.9

(58.8)

(21.3)

62.1

11.5

14.6

9.0

14.4

16.2

9.1

0.9

0.8

0.7

0.9

9.0

5.6

8.3

(100.0)

41.0

774,627

17,017

(44.6)

15.3

42.0

19.7

17.1

12.0

16.1

13.7

9.7

1.2

1.0

1.0

0.7

0.8

1.3

5.9

6.1

8.1

Unitech
Property

Cautious

Source: Company, Bloomberg, Kotak Institutional Equities estimates

0.3

KOTAK INSTITUTIONAL EQUITIES RESEARCH

India Daily Summary - February 16, 2011

Pharmaceuticals

31.7

Kotak Institutional Equities: Valuation summary of key Indian companies


15-Feb-11
Price (Rs)

Rating

Mkt cap.
(Rs mn)
(US$ mn)

O/S
shares
(mn)

2010

EPS (Rs)
2011E

2012E

EPS growth (%)


2010
2011E

2012E

2010

PER (X)
2011E

2012E

EV/EBITDA (X)
2010
2011E 2012E

Price/BV (X)
2010 2011E 2012E

Dividend yield (%)


2010 2011E 2012E

2010

RoE (%)
2011E

2012E

Target
price
(Rs)

Upside
(%)

ADVT-3mo
(US$ mn)

Sugar
Bajaj Hindustan

78

SELL

14,849

326

191

(7.9)

0.2

6.4

(343.6)

(102.5)

3,238.8

(9.9)

402.4

12.1

10.1

6.2

4.5

0.7

0.7

0.7

0.9

0.9

0.9

(7.1)

0.2

5.8

80

3.1

Balrampur Chini Mills

72

ADD

18,563

408

257

0.8

8.3

8.4

(89.9)

974.0

1.0

93.3

8.7

8.6

12.3

5.4

4.3

1.4

1.2

1.1

0.6

0.6

0.6

1.5

14.8

13.1

90

24.5

4.6
3.9

Shree Renuka Sugars

83

REDUCE

55,727

1,224

670

8.8

4.4

4.2

164.5

(49.8)

(4.2)

9.4

18.8

19.6

6.0

8.9

8.2

2.2

1.8

1.5

0.5

0.4

0.4

29.1

11.4

9.8

90

8.2

25.0

10.7

Cautious

89,140

1,958

(4.2)

11.6

21.3

19.3

17.3

14.3

8.0

7.0

5.7

1.5

1.3

1.2

0.6

0.5

0.5

7.7

7.7

8.2

HCL Technologies

483

REDUCE

338,100

7,428

700

17.5

22.8

29.6

0.2

30.3

29.4

27.6

21.2

16.3

13.6

12.8

10.1

4.8

4.3

3.7

0.8

1.6

1.7

19.3

21.7

24.5

440

(8.9)

Hexaware Technologies

107

BUY

15,428

339

144

9.3

5.1

10.4

127.7

(45.6)

104.3

11.5

21.1

10.3

6.2

13.9

7.0

1.8

1.7

1.5

0.9

0.9

0.9

17.8

8.2

15.0

125

16.4

BUY

1,783,160

39,173

574

108.3

120.0

155.2

5.7

10.8

29.3

28.7

25.9

20.0

21.1

18.0

13.8

7.7

6.9

5.6

0.8

1.9

1.5

30.1

28.1

30.9

3,700

19.1

74.5

76,028

1,670

1,176

2.5

3.1

4.3

(190.7)

24.7

37.4

26.0

20.9

15.2

12.0

11.9

7.1

4.0

3.6

3.4

58.5

18.5

23.2

70

8.3

15.4
0.7

Sugar
Technology

Infosys Technologies
Mahindra Satyam
Mindtree

3,107
65

REDUCE

6.1

449

REDUCE

18,471

406

41

52.2

27.1

41.5

294.3

(48.1)

53.1

8.6

16.6

10.8

7.4

8.8

5.6

2.8

2.4

2.0

0.5

0.6

0.9

35.2

15.4

19.9

500

11.4

Mphasis BFL

664

SELL

139,983

3,075

211

43.6

51.8

48.9

207.6

18.8

(5.5)

15.2

12.8

13.6

12.3

11.0

9.5

6.0

4.2

3.3

0.5

0.6

0.7

48.1

38.6

27.4

610

(8.2)

Polaris Software Lab

189

SELL

18,833

414

100

15.4

19.5

19.5

16.9

26.8

0.3

12.3

9.7

9.7

6.2

7.8

6.5

2.2

1.8

1.6

1.9

2.0

2.1

18.6

20.5

17.7

175

(7.4)

4.6

1,098

BUY

2,148,418

47,197

1,957

35.1

44.4

54.0

32.8

26.4

21.6

31.3

24.7

20.3

23.9

18.3

14.2

10.3

8.4

6.9

1.8

1.6

2.0

37.6

37.4

37.2

1,350

23.0

43.6

TCS
Tech Mahindra

636

Wipro

425

Technology

1,730

124

65.1

65.1

65.9

ADD

1,040,934

22,868

2,447

18.9

21.7

25.6

Attractive

REDUCE

5,734,798

78,763

125,984

(9.6)

(0.1)

1.3

9.8

9.8

9.6

8.0

8.7

8.1

2.7

2.2

1.9

0.5

0.3

0.3

34.5

26.3

5.9

22.1

720

13.3

3.2

22.1

15.2

17.7

22.6

19.6

16.7

17.1

14.3

11.6

5.3

4.4

3.6

0.8

1.0

1.3

26.5

24.4

23.7

525

23.4

18.1

24.6

17.4

21.1

26.0

22.1

18.3

18.7

15.9

12.5

6.8

5.8

4.8

1.2

1.7

1.6

26.1

26.3

26.3

24.4

14.3

38.1

Telecom
329

REDUCE

1,249,980

27,460

3,798

5.8

(27.7)

24.6

13.9

19.3

15.5

7.9

9.3

7.4

3.0

2.6

2.2

15.3

305

(7.3)

IDEA

62

REDUCE

204,588

4,494

3,300

2.7

2.4

1.2

(5.8)

(11.2)

(48.9)

22.7

25.5

50.0

8.0

9.0

7.8

1.8

1.7

1.6

7.2

6.9

3.5

55

(11.3)

MTNL

Bharti Airtel

44

SELL

27,815

611

630

(15.6)

(10.4)

(9.1)

(750.8)

(33.7)

(11.9)

(2.8)

(4.3)

(4.8)

1.0

1.2

1.6

0.3

0.3

0.3

(8.5)

(6.1)

(5.7)

35

(20.7)

1.3

Reliance Communications

102

SELL

216,557

4,757

2,133

19.7

6.9

7.9

(30.9)

(65.2)

15.0

5.1

14.8

12.9

6.5

8.2

7.4

0.5

0.5

0.5

0.8

11.0

3.3

3.7

90

(11.4)

23.9

Tata Communications

211

285

14.0

15.2

15.7

225

6.8

0.9

Telecom

REDUCE

60,021

1,319

Cautious

1,758,961

38,641
5,847

23.6

17.1

21.3

3.2

8.2

3.5

15.0

13.9

13.4

6.2

5.7

5.4

0.8

0.8

0.8

3.1

3.6

4.0

5.2

5.5

5.5

(12.3)

(38.9)

17.9

12.6

20.6

17.5

7.7

9.1

7.4

1.5

1.4

1.3

0.2

0.1

0.1

12.1

6.9

7.6

NM

155.8

7.6

Utilities
Adani Power

122

CESC

ADD

266,178

2,180

0.8

2.8

16.5

252.0

500.1

44.3

7.4

130.6

31.5

6.7

4.6

4.2

2.7

44.1

140

295

BUY

36,825

809

125

34.6

36.6

42.7

8.5

5.8

16.8

8.5

8.1

6.9

5.3

4.9

5.7

0.9

0.8

0.7

1.5

1.6

1.8

10.8

10.2

10.8

459

55.7

1.3

Lanco Infratech

40

BUY

96,441

2,119

2,405

2.1

3.6

4.9

46.6

67.4

36.6

18.8

11.2

8.2

12.2

8.5

6.5

2.9

2.3

1.8

17.4

21.0

22.5

80

99.5

8.6

NHPC

24

REDUCE

299,523

6,580

12,301

1.9

1.5

1.7

74.9

(19.4)

15.6

13.1

16.3

14.1

9.1

9.8

7.8

1.2

1.1

1.1

2.3

1.6

1.9

9.7

7.1

7.8

28

15.0

4.4

NTPC

181

REDUCE

1,491,605

32,768

8,245

10.5

10.1

11.9

6.8

(3.2)

17.6

17.2

17.8

15.2

2.0

2.1

1.9

2.3

14.1

12.6

13.7

195

7.8

Reliance Infrastructure

635

BUY

169,803

3,730

267

62.0

60.8

70.8

(1.0)

(1.9)

16.3

10.2

10.4

9.0

10.4

7.3

6.0

0.8

0.7

0.7

1.0

1.5

1.6

6.5

9.1

10.7

1,030

62.2

31.7

Reliance Power

121

SELL

340,256

7,475

2,805

2.9

2.9

4.0

179.7

0.1

38.4

42.5

42.5

30.7

(336.7)

237.0

51.1

2.4

2.1

2.0

4.8

5.2

6.6

115

(5.2)

12.7

1,269

ADD

313,146

6,879

247

63.5

70.7

84.4

26.7

11.3

19.4

20.0

17.9

15.0

12.3

12.4

11.6

2.4

2.2

2.0

0.9

1.1

1.2

13.8

13.0

14.0

1,415

11.5

7.1

3,013,776

66,208

22.6

3.6

37.2

19.2

18.6

13.5

14.5

14.5

10.9

2.0

1.8

1.7

1.4

1.3

1.5

10.4

9.9

12.3

Tata Power
Utilities

Cautious

13.2

13.4

12.1

2.3

2.2

4.2

9.9

14.7

4.0

11.8

Others
Havells India
Jaiprakash Associates

332

ADD

41,463

911

125

6.1

23.2

28.9

141.3

278.2

24.5

54.1

14.3

11.5

15.5

9.8

7.8

9.7

6.0

4.1

0.6

0.8

0.8

14.3

52.1

42.4

425

27.9

1.7

85

BUY

187,444

4,118

2,214

1.7

5.1

5.6

(12.7)

188.8

11.6

48.4

16.8

15.0

21.6

12.5

11.0

2.2

1.9

1.7

5.1

12.2

12.1

135

59.5

30.5

(71.7)

Jet Airways

488

BUY

42,129

926

86

(69.8)

25.6

58.7

(136.7)

129.5

(7.0)

19.1

8.3

12.4

7.8

6.4

2.4

2.2

1.7

12.0

23.0

850

74.2

19.8

Sintex

166

REDUCE

45,043

990

272

12.1

14.4

16.5

(49.6)

19.3

14.5

13.7

11.5

10.0

11.9

9.1

7.7

2.1

1.8

1.5

0.7

0.8

0.8

15.5

15.7

15.3

180

8.7

7.0

44

BUY

17,893

393

403

2.5

5.2

6.1

(117.4)

104.4

16.8

17.5

8.6

7.3

20.5

4.2

5.5

(5.2)

4.2

2.7

(15.9)

516.3

44.8

85

91.4

4.2

Tata Chemicals

320

REDUCE

77,951

1,712

243

26.4

26.8

35.4

(27.1)

1.5

31.9

12.1

11.9

9.1

6.4

5.7

4.3

1.7

1.5

1.3

2.8

3.0

3.0

16.0

16.9

19.3

370

15.5

3.9

United Phosphorus

143

BUY

1,456

462

11.9

12.9

17.6

220

53.5

6.9

SpiceJet

18.1

8.3

37.3

12.1

11.1

8.1

6.6

5.7

4.3

2.2

1.7

1.5

1.3

1.4

1.4

19.1

17.5

19.4

478,198

10,505

(539.8)

140.7

29.0

33.1

13.7

10.7

13.0

9.2

7.9

2.4

2.0

1.7

0.8

0.8

0.8

7.2

14.2

15.7

46,988,639

1,032,264

21.1

20.2

20.6

19.0

15.8

13.1

11.2

9.5

8.0

2.9

2.5

2.2

1.3

1.5

1.6

15.3

15.7

16.5

KS universe (b) ex-Energy

38,849,162

853,453

17.3

20.9

22.3

20.7

17.1

14.0

13.5

11.5

9.4

3.3

2.7

2.4

1.1

1.3

1.4

15.8

16.0

17.0

KS universe (d) ex-Energy & ex-Commodities

32,530,496

714,642

19.0

20.2

22.2

21.7

18.0

14.8

15.2

13.0

10.5

3.3

2.8

2.5

1.2

1.3

1.4

15.3

15.7

16.7

Others
KS universe (b)

66,274

Notes:
(b) 2010 means calendar year 2009, similarly for 2011 and 2012 for these particular companies.
(c) EV/Sales & EV/EBITDA for KS universe excludes Banking Sector.
(d) Rupee-US Dollar exchange rate (Rs/US$)=

45.52

Source: Company, Bloomberg, Kotak Institutional Equities estimates

30

India Daily Summary - February 1

(a) For banks we have used adjusted book values.

India Daily Summary - February 16, 2011

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Company

Disclosures

Kotak Institutional Equities Research coverage universe


Distribution of ratings/investment banking relationships
Percentage of companies covered by Kotak Institutional Equities,
within the specified category.

70%
60%

Percentage of companies within each category for which Kotak


Institutional Equities and or its affiliates has provided investment
banking services within the previous 12 months.

50%
40%
32.1%

33.3%

5.1%

5.1%

ADD

REDUCE

30%
23.1%
20%
11.5%
10%
3.2%

0.6%

0%
BUY

SELL

* The above categories are defined as follows: Buy = We expect


this stock to outperform the BSE Sensex by 10% over the next 12
months; Add = We expect this stock to outperform the BSE
Sensex by 0-10% over the next 12 months; Reduce = We expect
this stock to underperform the BSE Sensex by 0-10% over the
next 12 months; Sell = We expect this stock to underperform the
BSE Sensex by more then 10% over the next 12 months. These
ratings are used illustratively to comply with applicable
regulations. As of 30/09/2010 Kotak Institutional Equities
Investment Research had investment ratings on 156 equity
securities.

Source: Kotak Institutional Equities

As of September 30, 2010

Ratings and other definitions/identifiers


Definitions of ratings
BUY. We expect this stock to outperform the BSE Sensex by 10% over the next 12 months.
ADD. We expect this stock to outperform the BSE Sensex by 0-10% over the next 12 months.
REDUCE. We expect this stock to underperform the BSE Sensex by 0-10% over the next 12 months.
SELL. We expect this stock to underperform the BSE Sensex by more than 10% over the next 12 months.
Our target price are also on 12-month horizon basis.

Other definitions
Coverage view. The coverage view represents each analysts overall fundamental outlook on the Sector. The coverage view will consist of one of the following
designations: Attractive, Neutral, Cautious.

Other ratings/identifiers
NR = Not Rated. The investment rating and target price, if any, have been suspended temporarily. Such suspension is in compliance with applicable
regulation(s) and/or Kotak Securities policies in circumstances when Kotak Securities or its affiliates is acting in an advisory capacity in a merger or strategic
transaction involving this company and in certain other circumstances.
CS = Coverage Suspended. Kotak Securities has suspended coverage of this company.
NC = Not Covered. Kotak Securities does not cover this company.
RS = Rating Suspended. Kotak Securities Research has suspended the investment rating and price target, if any, for this stock, because there is not a sufficient
fundamental basis for determining an investment rating or target. The previous investment rating and price target, if any, are no longer in effect for this stock
and should not be relied upon.
NA = Not Available or Not Applicable. The information is not available for display or is not applicable.
NM = Not Meaningful. The information is not meaningful and is therefore excluded.

31

KOTAK INSTITUTIONAL EQUITIES RESEARCH

Corporate Office

Overseas Offices

Kotak Securities Ltd.

Kotak Mahindra (UK) Ltd

Kotak Mahindra Inc

Bakhtawar, 1st Floor

6th Floor, Portsoken House

50 Main Street, Suite No.310

229, Nariman Point

155-157 The Minories

Westchester Financial Centre

Mumbai 400 021, India

London EC 3N 1 LS

White Plains, New York 10606

Tel: +91-22-6634-1100

Tel: +44-20-7977-6900 / 6940

Tel:+1-914-997-6120

Copyright 2011 Kotak Institutional Equities (Kotak Securities Limited). All rights reserved.
1.

Note that the research analysts contributing to this report may not be registered/qualified as research analysts with FINRA; and

2.

Such research analysts may not be associated persons of Kotak Mahindra Inc and therefore, may not be subject to NASD Rule 2711 restrictions on
communications with a subject company, public appearances and trading securities held by a research analyst account.

Kotak Securities Limited and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We along with
our affiliates are leading underwriter of securities and participants in virtually all securities trading markets in India. We and our affiliates have investment banking
and other business relationships with a significant percentage of the companies covered by our Investment Research Department. Our research professionals
provide important input into our investment banking and other business selection processes. Investors should assume that Kotak Securities Limited and/or its
affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that the research
professionals who were involved in preparing this material may participate in the solicitation of such business. Our research professionals are paid in part based on
the profitability of Kotak Securities Limited, which include earnings from investment banking and other business. Kotak Securities Limited generally prohibits its
analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that
the analysts cover. Additionally, Kotak Securities Limited generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or
advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals may provide oral or written market commentary
or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may
make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of
the foregoing, among other things, may give rise to real or potential conflicts of interest. Additionally, other important information regarding our relationships with
the company or companies that are the subject of this material is provided herein.
This material should not be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would
be illegal. We are not soliciting any action based on this material. It is for the general information of clients of Kotak Securities Limited. It does not constitute a
personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice
or recommendation in this material, clients should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The
price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any
investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. Kotak Securities
Limited does not provide tax advise to its clients, and all investors are strongly advised to consult with their tax advisers regarding any potential investment.
Certain transactions -including those involving futures, options, and other derivatives as well as non-investment-grade securities - give rise to substantial risk and are
not suitable for all investors. The material is based on information that we consider reliable, but we do not represent that it is accurate or complete, and it should
not be relied on as such. Opinions expressed are our current opinions as of the date appearing on this material only. We endeavor to update on a reasonable basis
the information discussed in this material, but regulatory, compliance, or other reasons may prevent us from doing so. We and our affiliates, officers, directors, and
employees, including persons involved in the preparation or issuance of this material, may from time to time have long or short positions in, act as principal in,
and buy or sell the securities or derivatives thereof of companies mentioned herein. For the purpose of calculating whether Kotak Securities Limited and its affiliates
holds beneficially owns or controls, including the right to vote for directors, 1% of more of the equity shares of the subject issuer of a research report, the holdings
does not include accounts managed by Kotak Mahindra Mutual Fund. Kotak Securities Limited and its non US affiliates may, to the extent permissible under
applicable laws, have acted on or used this research to the extent that it relates to non US issuers, prior to or immediately following its publication. Foreign currency
denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the
investment. In addition, investors in securities such as ADRs, the value of which are influenced by foreign currencies affectively assume currency risk. In addition
options involve risks and are not suitable for all investors. Please ensure that you have read and understood the current derivatives risk disclosure document before
entering into any derivative transactions.
This report has not been prepared by Kotak Mahindra Inc. (KMInc). However KMInc has reviewed the report and, in so far as it includes current or historical
information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. Any reference to Kotak Securities Limited shall also be
deemed to mean and include Kotak Mahindra Inc.

You might also like